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CLINICAL AND BIOCHEMICAL STUDIES ON 
SENILE CATARACT 
 
ABSTRACT 
AIM:  
 To determine the frequency of occurrence of different types of senile 
cataract and  assess  the possible  putative  correlations with lenticular protein 
profiles and to compare visual outcomes and factors influencing them, in 
patients undergoing small incision cataract surgery (SICS) and  
phacoemulsification cataract surgery at a tertiary eye care hospital in India. 
PATIENTS AND METHODS: 
 520 patients-130 in the SICS group and 390 in the phaco group were 
enrolled in the study. The putative factors influencing the outcome of surgery, 
such as gender, the presurgical presence of systemic co-morbid conditions and 
of ocular conditions, and the degree of nuclear sclerosis of the cataractous lens, 
was ascertained. Differences in degree of visual improvement between the two 
surgical groups were sought .An attempt was made to study the human lens 
proteomics , by subjecting varying grades of nuclear cataract to sodium dodecyl 
polyacrylamide gel electrophoresis (SDS-PAGE) and 2DE analytical 
techniques, and the results obtained, were analysed.  
Results:  
 Analysis of lenticular profiles revealed that NC3 was the most common 
cataract among males and in the SICS group, whereas NC4 was more common 
among females and in the phaco group. There was no difference in post-
operative mean visual acuity  between SICS and phaco in males, although such 
a difference existed in females with better visual acuity in the phaco group. 
Proteomic studies showed that the cataractous lens samples showed a  
statistically significant  reduction in  band intensity on SDS-PAGE and  
subsequently done two dimensional gel electrophoresis (2-DE) and MALDI-
TOF analysis revealed  varying levels of alpha-crystallins in the cataractous lens 
Conclusion:  
 Both SICS and phacoemulsification yield satisfactorily similar visual 
outcomes and  there are no other obvious factors such as grade of cataract, 
associated ocular and systemic comorbid conditions, that would favour 
choosing one procedure rather than the other. Additional biochemical studies on 
various grades of human cataract may help in identifying factors triggering 
cataractogenesis 
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INTRODUCTION 
 
The eye is a highly specialized organ, which provides a view of the 
surrounding world by converting incident light into electrical signals that 
are interpreted by the brain. The human crystalline lens is meant to be 
transparent to enable it to focus visible light (400-700 nm) on the retina of 
the eye, providing increased sensitivity and allowing the information 
contained by that light to be spatially resolved.1,2  
The term ‘cataract’ refers to a clouding or opaque area over the 
transparent ocular lens, which occurs when some of the proteins in the lens 
begin to aggregate, the end-result being impairment of vision3. Children 
may occasionally be born with the condition, or cataract may occur 
secondary to ocular injury or inflammation, to refractive errors such as 
myopia or to systemic diseases such as hypertension and diabetes mellitus. 
However, by far, the condition is mostly related to increasing age4. In fact, 
since cataract most commonly appears in elderly individuals, it is 
frequently referred to as “senile cataract”; if cataract develops before the 
age of 60, it may be called a “presenile” cataract. 
It has been estimated that, globally, approximately 45 million people 
worldwide are blind, half of them due to cataract5,6,7. However, changing 
demographic structures of populations, particularly the increasing 
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proportion of the elderly, and enhanced life expectancy in the developing 
world, suggest that this number will increase dramatically in the coming 
years. In fact, projections by the World Health Organisation indicate that in 
2020, close to 40 million people will be blind due to cataract8,9. In India, 
cataract has been reported to be responsible for 50-80% of bilateral 
blindness10,11,12. Thus, it is essential that all possible measures be taken to 
tackle this condition which may be responsible for a diminution in the 
quality of life.  
At present, the most effective treatment of cataract is the surgical 
removal of the opacified lens; however, there continues to be a backlog of 
the services provided in many parts of the world. Globally, the two main 
techniques of cataract surgery are manual small incision cataract surgery 
and phacoemulsification; a third technique, microincision cataract surgery, 
is becoming increasingly popular13.  
In phacoemulsification, first described in 1967 by Charles D. 
Kelman, there is ultrasonic fragmentation of the crystalline lens, and a 
small incision (with a standard size of around 2.75 mm); this technique 
permits rapid visual rehabilitation postoperatively and low- induced 
astigmatism. However, capital investment and recurring costs are high, and 
extensive surgical training is required. Manual small incision cataract 
surgery, first described by Blumental et al. (1992)14, is popular in Asia and 
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Africa since it is considerably less costly than phacoemulsification while 
still offering rapid visual recovery and reduced astigmatism. A 6 mm to 6.5 
mm scleral incision allows the insertion of a 6 mm intraocular lens (IOL); 
the posterior capsule of the lens is left intact. 
With increasing safety of ocular surgical techniques and improved 
visual results, it is no longer necessary to wait for the cataract to become 
sufficiently mature; in fact, surgery can be performed at a much earlier 
stage when phacoemulsification is used15. Cataract surgery may be 
performed depending on the patient’s age and visual function 
demands16.Certain surgical complications can be avoided if the cataract is 
removed before it becomes too advanced17. Surgery should be considered 
when the benefits from removal of symptoms outweigh the small risks 
caused by modern surgery18. 
With increasing volumes of cataract surgery in many parts of the 
world, the importance of well-performed reviews is being increasingly 
recognized. Publications have described outcome of cataract surgery, 
possible complications and improvements in final visual acuity19,20. 
However, additional information is needed with reference to factors that 
possibly influence outcomes, such as the gender of the patient, the 
presence of systemic co-morbid conditions, the type of surgery done and 
the degree of sclerosis of the cataract.  
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Two-dimensional gel electrophoresis (2-DE) and mass spectrometric 
(MS) analysis are the tools used in the emerging field of proteomics21; 
these hold great promise for determining putative modifications in 
lenticular structure that contribute to cataractogenesis. 2-DE is capable of 
simultaneously resolving complex mixtures of modified crystallins, which 
are then quantified by image analysis, and, subsequently, post-translational 
modifications on excised spots can be determined by MS. There are few 
studies on proteomic aspects of human lenses, and fewer studies on 
cataractous lens of varying degrees of nuclear sclerosis.  
In the present study, an analysis was done of patients undergoing 
small incision cataract surgery (SICS) and phacoemulsification cataract 
surgery at a tertiary eye care hospital. Differences in degree of visual 
improvement between the two surgical groups were sought. In addition, 
putative factors influencing the outcome of surgery, such as gender, the 
presurgical presence of systemic co-morbid conditions and of ocular 
conditions, and the degree of nuclear sclerosis of the cataractous lens, were 
sought. In addition, cataractous lenses of varying grades of sclerosis were 
subjected to sodium dodecyl polyacrylamide gel electrophoresis (SDS-
PAGE) and 2DE analytical techniques, and the results obtained were 
analysed.  
  
Aim of the Study 
5 
AIMS OF THE STUDY 
 
 To compare outcomes in patients undergoing small incision cataract 
surgery (SICS) and outcomes in patients undergoing phacoemulsification 
cataract surgery at a tertiary eye care hospital in India.  
Primary outcome measures 
1. To determine the frequency of occurrence of different types of senile 
cataract (based on the Lens Opacities Classification System [LOCS] 
Version III) in patients about to undergo cataract surgery. 
2. To compare the proportions of individuals achieving good functional 
vision (presenting visual acuity better than or equal to 6/12 in the 
operated eye) following small incision cataract surgery with the 
proportions achieved in individuals undergoing phacoemulsification 
cataract surgery. 
3. To identify putative factors influencing post-operative visual 
outcome, such as age, gender, types of senile cataract and presence 
of co-morbid systemic diseases (esp. diabetes mellitus & 
hypertension),  
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Secondary outcomes 
1. To note the occurrence of intraoperative complications such as 
posterior capsular rent and other complications as reported. 
2.  To note the occurrence of early post-operative complications.  
3.  To determine putative correlations between different types of senile 
cataract and lenticular protein profiles. 
  
Review of Literature 
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REVIEW OF LITERATURE 
 The human lens is a cellular organ, its stability and transparency 
occurring as a result of tight packing of crystalline proteins into a glass-
like microarchitecture. Senile (age-related cataracts), one of the 
commonest types of acquired cataracts, affects equally persons of either 
gender, usually above the age of 50 years. By the age of 70 years, more 
than 90% of individuals are likely to have developed a senile cataract. The 
condition is usually bilateral, but, for the most part, one eye is affected 
earlier than the other. 
  Anatomically speaking, the human lens can be divided into two 
principal regions, namely, the nucleus and the cortex. While the nucleus is 
present at birth, the cortex tends to be formed by differentiation of the 
lenticular epithelial cells throughout life22. Concomitant with the 
maturation of lenticular fibres, intracellular organelles, such as the 
mitochondria, tend to degenerate23. Thus, mature lenticular fibres tend to 
be devoid of cytoplasmic organelles, so that the bulk of the lens is made up 
of lipid membranes packed with lenticular proteins. This high 
concentration of structural proteins (lenticular crystallins) leads to an 
increase in the refractive index of the lens24. Any aberration in the structure 
or quantum of specific lenticular crystallins can lead to cataract25.  
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 Senile cataractogenesis is essentially related to the ageing process. 
Although its precise etiology is unknown, various factors are implicated, 
such as heredity, ultraviolet radiation, dietary factors, childhood 
dehydrational crises and smoking22. These factors tend to influence the age 
of onset, type and maturation of senile cataract. Heredity plays an 
important role in the age of onset, incidence and maturation of senile 
cataract in different families26,27,28,29,30,31. Ultraviolet radiation has been 
implicated in the early onset and maturation of senile cataract, based on the 
observations made in several epidemiological studies32,33,34,35,36. Javitt and 
Taylor33 found that the latitude of an individual’s residence correlated 
directly with the UV-B content of sunlight, because the incident angle of 
the sun determines the atmospheric penetration of ultraviolet radiation. 
Interestingly, although a consistent dose-dependent association between 
ocular UV-B exposure and two common types of cataract (cortical and 
posterior subcapsular) has been shown by epidemiological studies, the 
same studies (unlike experimental studies)did not provide sufficient 
evidence to link UV-B exposure to senile macular degeneration in 
humans32.  
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 A diet that is deficient in some proteins, vitamins (riboflavin, 
vitamins C and E) or essential elements has also been blamed for early 
onset and maturation of senile cataract37,38.  
 The incidence of three different cataract types tends to increase with 
age: nuclear cataracts, which account for approximately 60% of age-
related cataracts; cortical cataracts which account for approximately 30% 
and posterior subcapsular cataracts, which account for the remaining 
10%39.Klein et al.39 described the cumulative incidence of age-related 
cataracts and cataract surgery over a 10-year interval through a prospective 
epidemiologic study on persons aged 43 to 86 years who were participating 
in the Beaver Dam Eye Study; there were 4926 individuals at baseline and 
2764 individuals for first, five-year and ten-year follow-ups. 
 Photographs of the lens in each patient were taken using specially 
modified cameras and graded per codified rules by trained graders into 
nuclear, cortical, and posterior subcapsular cataracts. It was found that in 
right eyes, incident nuclear cataract occurred in 19.4%, cortical cataract in 
17.4%, posterior subcapsular cataract in 6.1%, and cataract surgery in 
10.8%. The incidence of all these end-points was found to be increased 
with age. Women had significantly higher incidences of nuclear cataract 
and cataract surgery than men. Time trends seemed to be influencing the 
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incidence of cataract surgery. These authors concluded that age-related 
cataracts are common events in aging, and that age-specific cataract 
surgery incidence seemed to be increasing. 
With cataract being the leading cause of preventable blindness 
worldwide, cataract surgery is one of the most frequently performed 
operations in the world16. Hatch et al.40 sought to estimate cataract surgery 
rates for the province of Ontario (Canada’s largest province [state] with a 
population of about 13 million), by direct standardization of age- and sex-
specific cataract surgery rates, obtained from the Ontario Health Insurance 
Plan Database, to Ontario’s population projections; they found that the 
need for cataract surgery in this region was likely to more than double in 
the ensuing 25 years (the study was done in 2012). 
Advancements in phacoemulsification and intraocular lens (IOL) 
technology have ushered in a new era of cataract surgery. Over the years, 
innovations in IOL design and phacoemulsification instrumentation have 
potentiated improved surgical outcomes, reduced perioperative morbidity 
and increased likelihood of spectacle independence16. A big step forward 
in improved surgical techniques of cataract surgery and improved 
outcomes was the gradual introduction of operating microscopes during the 
1970s. These operating microscopes offered better intraocular visibility 
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and ability to safely place multiple corneal sutures. In addition, such 
microscopes provide the advantages of leaving the posterior capsule intact, 
leading to a reduced risk of potentially blinding complications, such as 
vitreous loss or retinal detachment, and also permitting the implantation of 
an IOL in the posterior chamber.  
 Currently, phacoemulsification is the standard of care for cataract 
extraction in the western world. The major advantage of 
phacoemulsification is that it has reduced the morbidity from cataract 
surgery by reducing the incision size with subsequent faster recovery and 
decreased risk of complications including endophthalmitis. In addition, the 
learning curve for this procedure seems to be remarkably small. Meeks et 
al. (2013)41 reported on a retrospective cohort evaluation of the safety and 
efficacy of phacoemulsification cataract extraction and manual 
extracapsular cataract extraction performed by beginning resident surgeons 
in a medical centre in Dallas, Texas, USA. A review was performed of 
each resident's (post-graduate student) series of initial cataract surgery 
procedures as a late first-year or second-year resident. Data were collected 
for cases performed over almost a 6-year period during which initially the 
first primary surgeon cases were extracapsular cataract extraction and, 
later, the first primary surgeon cases were phacoemulsification. 
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Complications (vitreous loss or dropped nucleus) occurred in six (2.5%) of 
244 cases in which phacoemulsification was performed by a beginner 
resident primary surgeon and in seven (4.1%) of 172 cases in which 
extracapsular cataract extraction was performed. Posterior chamber IOLs 
were placed in all but two phacoemulsification cases and four patients in 
whom extracapsular cataract extraction was peformed. Moreover, three 
cases in the phacoemulsification group and one in the group that had 
undergone extracapsular cataract extraction required a reoperation within 
90 days. These authors concluded that phacoemulsification cataract 
extraction can be taught safely and effectively to residents with no cataract 
surgery experience as a primary surgeon. 
Mithal et al. (2012)42 evaluated the outcome of manual SICS under 
topical anesthesia with lignocaine 2% jelly in a prospective interventional 
case series involving 128 patients with senile cataract; intra-cameral 
anesthesia was not used, and there was only a single operating surgeon. 
More than 55% of patients did not experience pain, while more than 90% 
had mild to no pain. Complications occurred in only two of the surgeries, 
while the surgeon reported a favourable experience with regard to the 
cooperation of the patients, stability of the anterior chamber, relative ease 
of surgery and relative absence of complications. Interestingly, a study in 
13 
200443 on 120 patients surveyed just before and one month after surgery 
found that there was a wide gap between expectations and what was 
actually achieved. While 60% of patients expected to achieve a perfect 
Visual Function Index score, and the average expected score was 96.1, the 
score actually achieved was 89.8; it was found that patients harboured 
unrealistic expectations regarding driving at night, reading small print, and 
doing fine handiwork. Surprisingly, improvement in visual function did 
not correlate with satisfaction in vision. The author of the study felt that 
the results highlighted the highly unrealistic expectations harboured by 
patients with cataract and underscored the need for physicians to attempt to 
control the expectations of their patients; the author even went so far as to 
say that controlling patient expectations was probably more effective than 
improving patients’ postoperative outcome in terms of maximizing patient 
satisfaction43. 
 Several studies have tried to evaluate visual outcomes of SICS 
versus that in phacoemulsification Gogate et al. (2007)44 sought to 
compare the cost of phacoemulsification cataract surgery, using foldable 
lenses, with that of manual SICS in a hospital setting in India through 
fixed-facility and recurrent (consumables) costing for both the surgeries 
based on information collected at different sources using standard norms. 
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Prior to this, a single masked randomized controlled clinical trial had been 
conducted to compare the safety and efficacy of the two techniques for 
rehabilitation of the cataract patient. The participants included 400 patients 
and four surgeons.The average cost of a phacoemulsification surgery for 
the hospital was Indian rupees (INR) 1978.89 while that of the SICS 
surgery was INR 720.99, with INR 500.99 being the fixed-facility cost 
common to both. The cost of phacoemulsification cataract surgery was 
higher due to the cost of the foldable lens used. Moreover, 
phacoemulsification required additional expenditure to cover the financial 
depreciation of the instrument, the replacement of faulty or old parts, and 
cost of the annual maintenance contract. These authors concluded that 
manual SICS is far more economical than phacoemulsification, safe and 
yields a visual result that is comparable with that of phacoemulsification.  
 In a prospective randomised study in Nepal, Ruit et al. (2007)45 
sought to compare the efficacy and visual results of phacoemulsification 
with that of manual sutureless SICS in 108 consecutive patients with 
visually significant cataracts.Both surgical techniques were found to 
achieve excellent surgical outcomes with low complication rates. On 
postoperative day 1, the groups had comparable uncorrected visual acuity 
(UCVA) while the SICS group had significantly less corneal edema. At six 
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months, 89% of the SICS patients had uncorrected visual acuity of 20/60 
or better and 98% had a best-corrected visual acuity of 20/60 or better 
versus 85% of the patients in the phacoemulsification group with 
uncorrected visual acuity of 20/60 or better and 98% with best corrected 
visual acuity of BCVA of 20/60 or better; this difference was not 
statistically significant. Interestingly, the surgical time for SICS was found 
tobe significantly shorter than that taken to perform phacoemulsification. 
These authors concluded that both phacoemulsification and SICS achieved 
excellent visual outcomes with low complication rates. However, they also 
opined that since SICS is significantly faster, less expensive, and less 
dependent on high-end technology than is phacoemulsification, SICS 
might be the more appropriate surgical procedure for the treatment of 
advanced cataracts in the developing world. 
 Singh et al. (2009)46 sought to compare the safety and efficacy of 
different types of surgical procedures (phacoemulsification versus SICS) 
for cataract surgery in immature cataract.  
 In this prospective randomized controlled trial performed on 93 and 
89 patients with immature senile cataract selected for phacoemulsification 
and SICS, respectively, there was no significant difference between the 
groups in terms of gender, age and pre-operative visual acuity. More than 
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two- thirds of patients in the phacoemulsification group and more than 
three quarters of the patients in the SICS group had good visual outcome 
(6/6-6/18) on the first postoperative day; this difference was not 
statistically significant. Poor outcome (<6/60) was recorded in 6% 
(phacoemulsification group) and 1% (small incision cataract surgery 
group). Mean visual acuity was 0.43 +/- 0.27 in the phacoemulsification 
group and 0.47 +/- 0.24 in the SICS group. Interestingly, the mean time for 
surgery was statistically significantly shorter in the SICS group than in the 
phacoemulsification group. These authors concluded that SICS cataract 
surgery with implantation of a rigid polymethmethylacrylate lens is a 
suitable surgical technique to treat immature cataract in developing 
countries. 
Wong47, who examined rates of cataract extraction in Singapore, 
found that the average rate was highest for Indians (about 396.5 per 100, 
000/year), followed by Chinese (371.2 per 100, 000/year) and Malays 
(only 237.2 per 100, 000/year); it was also found that women had higher 
rates of cataract extraction than men, and this pattern was seen across the 
three racial groups. This investigator was of the opinion that these racial 
variations suggested varying predisposition to cataract development and/or 
the threshold for cataract surgery. Gupta et al. (2013)48, who sought to 
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determine the prevalence of cataract surgery as well as factors in 
association with post-surgical outcomes of vision in migrant Indians living 
in Singapore, conducted a population-based study in 3, 400 Indian 
immigrants residing in Singapore. Post-operative visual impairment was 
defined as best-corrected or presenting visual acuity of 20/60 or worse. 
The age- and gender-standardized prevalence of cataract surgery was 9.7% 
in Singapore resident Indians, while the post-operative visual impairment, 
as defined by best corrected visual acuity, was found to occur in 10.9% of 
the eyes studied. The main causes of this impairment were found to be 
diabetic retinopathy, posterior capsular opacification, and age-related 
macular degeneration. These authors48 concluded that socioeconomic 
variables and migration did not significantly contribute to the prevalence 
of cataract surgery, and that diabetic retinopathy was a major cause of 
postoperative visual impairment in migrant Indians living in Singapore. A 
study conducted in Fukui (Japan) echoed similar findings (Morikubo et al. 
2004)49. No significant differences were observed in any preoperative 
parameter between diabetic and nondiabetic individuals. However, there 
was a significantly higher increase in corneal thickness one month post- 
surgery, and significantly greater losses of corneal endothelial cells at one 
day and one week after surgery, in diabetics than in non-diabetics.  
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Lam et al. (2007)50 sought to evaluate the visual acuity and 
astigmatism of individuals undergoing manual cataract extraction by local 
surgeons in rural China over a 4 month period. 
 Among 313 eligible subjects, 242 (77%) could be contacted, of 
whom1 176 (73%) were examined. Of those examined, mean ± SD age 
was 69.3±10.5 years, and 66.5% were female; 35 had been operated on 
bilaterally at Sanrao, and 85.2% had a preoperative presenting visual 
acuity of 6/60 or worse. Presenting and best-corrected postoperative acuity 
in the eye that was operated on were 6/18 or better in 83.4% and 95.7%, 
respectively.  
Skiadaresi et al. (2012)51 found poor correlations between cataract 
morphology and visual symptoms with the exception of the correlation 
found between blurred vision and posterior subcapsular cataracts. 
Although excellent outcomes are frequently reported for cataract 
surgery in urban areas of China and India, the same cannot be said for rural 
areas of Asia, wherein poor visual outcomes, low visual function and 
quality of life and poor utilization of rehabilitation services after cataract 
surgery are often reported. To address this issue, Congdon and associates 
(2007)52 sought to evaluate the postoperative visual function and utilization 
of refraction and second-eye surgical facilities available to individuals 
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undergoing cataract surgery in rural China. Interestingly, although visual 
function was high in this group of individuals and there was substantial 
potential benefit if refraction and second-eye surgery services were 
utilized, actual uptake of services was modest because individuals did not 
feel the need to do so. The authors concluded that programs to improve the 
utilization of services needed to focus on provision of reading glasses and 
on strategies to reduce costs52.  
 Lai et al. (2013)53 investigated the clinical outcomes of cataract 
surgery in 207 individuals aged 90 and older who underwent cataract 
surgery for primary senile cataracts. 
 Interestingly, 79.7% of the 207 participants (mean age 92.0 ± 2.1), 
79.7% achieved visual improvement after cataract surgery in spite of a 
high incidence of systemic comorbidities such as hypertension (66.2%), 
diabetes mellitus (25.1%), and myocardial infarction (19.8%), as well as 
ocular comorbidities such as age-related macular degeneration (15.9%), 
glaucoma (10.6%), and myopic degeneration (5.3%). The most common 
complications were vitreous loss (8.2%), posterior capsular rupture (7.2%), 
and zonular rupture (4.8%). The authors concluded that despite a high 
prevalence of systemic and ocular comorbidities in very elderly adults, 
good clinical outcomes of cataract surgery were attainable53.  
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Crystallins are structural proteins which possess the ability to form 
soluble oligomers in high concentrations; specific, short range interactions 
are also possible, which increase refractive power of the lens and maintain 
transparency54.Crystallins are divided into three major classes, termed as 
alpha-, beta- and gamma-crystallins55. 
Alpha crystallin, a member of the small heat shock protein family of 
molecular chaperones, is an aggregate of two polypeptides, namely, alpha-
A and alpha-B crystallins, that share 55% aminoacid sequence identity56. 
Alpha crystallin has chaperone- like properties, being capable of binding to 
unfolded or denatured proteins and suppressing non-specific 
aggregation57.The chaperone activity of alpha crystallin helps to prevent 
the formation of large light- scattering aggregates, inactivation of enzymes, 
and, possibly, cataract formation58,59. Thus, alpha A crystallin is of much 
importance in development of the lens and in the development and 
maintainenance of lenticular transparency. 
In the Beta crystallin superfamily, beta-crystallins have seven 
primary gene products; four of these are acidic, namely beta A1, beta A2, 
beta A3 and beta A4), while three are basic, namely, beta B1, beta B2, and 
beta B355,60,61. An important function of beta B1 is in controlling the higher 
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assembly of beta crystallins and the potential role of truncated versions of 
the protein in cataract formation have also been reported62.  
 Cataract-specific forms of alpha-, betaB1 and B2-crystallins have 
been observed to lack from 5 to 22 residues in their termini. Truncated 
forms of alpha- and beta- crystalline were also observed to be more 
abundant in the water insoluble fraction, suggesting that their truncation 
may contribute to the formation of insoluble protein in cataractous lenses. 
Loss of 11 or more C-terminal residues in alpha-crystallin dramatically 
decreases its chaperone activity63. 
 Two-dimensional electrophoresis (2-DE) and mass spectrometric 
analysis (MS) are the tools in the emerging field of proteomics21; these 
hold a great promise in determining the modifications in lenticular 
crystalline proteins that contribute to cataractogenesis. 2-DE is capable of 
simultaneously resolving complex mixtures of modified crystallins. These 
resolved crystallins can be then quantified by image analysis, and then, 
subsequently, post- translational modifications on excised spots can be 
determined by MS. 
The review of literature emphasizes the fact that there are still 
various aspects of cataract and cataract surgery that need to be studied. 
This underlines the relevance of the current study, in which an analysis has 
22 
been made of patients undergoing small incision cataract surgery (SICS) 
and phacoemulsification cataract surgery at a tertiary eye care hospital. 
Previous studies have not reported significant differences in final visual 
outcome between these two types of surgery, so, in the current study, 
differences in degree of visual improvement between the two surgical 
groups were sought. Different authors have reported on various factors that 
may possibly influence the outcome of therapy. Hence, in the present 
study, putative factors influencing the outcome of surgery, such as gender, 
the presurgical presence of systemic co-morbid conditions and of ocular 
conditions, and the degree of nuclear sclerosis of the cataractous lens, were 
sought. Increasingly, proteomic studies of cataractogenesis are being 
performed in a bid to unravel the mechanisms leading to the development 
of cataract. There have been many studies on experimental cataracts, but 
comparatively fewer on human cataracts. Hence, in the present study, 
human lenses with varying grades of nuclear cataract were subjected to 
sodium dodecyl polyacrylamide gel electrophoresis (SDS-PAGE) and 2DE 
analytical techniques, and the results obtained were analysed.  
  
Materials & Methods 
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MATERIALS AND METHODS 
Clinical aspects of the present dissertation were studied in patients 
presenting with diminished vision due to lenticular opacification at the 
Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirapalli, 
Tamilnadu, over a period of 11 months (December 1, 2011 to October 31, 
2012). Biochemical aspects were studied concurrently. Clinical and 
biochemical data were analysed and interpreted subsequently (March 2013 
to September 2013). The study had the approval of the Institutional 
Review Board and conformed to the tenets of the Declaration of Helsinki ; 
written informed consent was also obtained from each patient. 
CLINICAL ASPECTS 
Over an 11-month period, 604 patients with diminished vision due 
to cataract were seen. Of these, 22 individuals did not provide consent to 
participate while 30 individuals could not be enrolled due to the presence 
of one, or multiple, exclusion criteria. During data analysis, it was found 
that records of an additional 32 patients were incomplete. Hence, analysis 
could be performed for the clinical aspects of the study only on 520 
patients. 
Study design: This was a prospective, comparative interventional study 
done on patients presenting with various grades of cataract over an 11-
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month period, the available interventions being small incision cataract 
surgery (SICS) or phacoemulsification cataract surgery. Provided that there 
was no specific indication to perform one particular intervention (SICS or 
phacoemulsification), the selection of the intervention was based on the 
patient’s choice.  
Sample size calculation: A key parameter to be investigated in the current 
study was the visual acuity following SICS or phacoemulsification cataract 
surgery. Based on published data, it was hypothesized that 
phacoemulsification surgery would yield a marginally better post-operative 
mean visual acuity than that achieved by SICS, and that this difference 
could be shown to be statistically significant by a Student `t’ test. To 
calculate the minimum total sample size (two-tailed hypothesis) and 
minimum sample size per group (two-tailed hypothesis), the parameter 
values defined were: 
a) Anticipated effect size (Cohen’s d): 0.5 
b) Desired statistical power level (β-error): 0.8 (80%) 
c) Probability level (α –error): 0.05 
 Calculation was done using an A-priori sample size calculator for 
Student `t’ tests at the URL: http://www.danielsoper.com/statcalc3/calc, 
which yielded the following result: 
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Minimum total sample size (two-tailed hypothesis): 128 
Minimum sample size per group (two-tailed hypothesis): 64.  
 In actual fact, a total of 520 patients were enrolled in the clinical 
study (130 in the SICS group; 390 in the phacoemulsification group)  
Inclusion Criteria: Patients were considered for inclusion in the study if: 
- they provided written informed consent, and were 40 to 70 years of 
age; 
- exhibited normal anterior segment morphology (other than for the 
presence of senile cataract in one or both eyes); 
- showed normal intraocular pressure (IOP) or senile cataract with 
primary open angle glaucoma under medical management (with or 
without control of IOP), or intumescent lens with narrow angles on 
gonioscopy (without any peripheral anterior synechiae); 
- exhibited a normal fundus or ultrasound B-scan evidence of a 
normal posterior segment; 
- exhibited patent naso-lacrimal ducts on syringing; or 
- had systemic hypertension, diabetes mellitus or 
hypercholesterolemia that was under control with medical 
management. 
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Exclusion criteria: Patients were not considered for the current study if 
they exhibited any one of the following exclusion criteria: 
- declined to undergo surgery; 
- were less than 45 years of age; 
- suffered from uncorrected high refractive errors or amblyopia ; 
- had a conjunctival swab report showing significant growth of 
potentially pathogenic bacteria; 
- had nasolacrimal duct obstruction due to untreated acute or chronic 
nasolacrimal duct infection; 
- suffered from nystagmus or congenital anomalies of the eye;  
- suffered from external ophthalmoplegia with or without multiple 
cranial nerve palsies;  
- suffered from corneal opacities (nebula, leucoma), dystrophies and 
degenerations;  
- exhibited active allergic, infective or inflammatory conditions such 
as episcleritis, scleritis, conjunctivitis, keratitis, anterior, 
intermediate or posterior uveitis, optic or retrobulbar neuritis  or 
infective foci anywhere in the body; 
- suffered from traumatic cataract, complicated cataract or polar 
cataract;  
- suffered from phacolytic glaucoma;  
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- suffered from intraocular, intraorbital or systemic malignancies; 
- had a B-scan showing posterior segment abnormalities other than 
normal age-related changes;  
- suffered from uncontrolled systemic hypertension, diabetes mellitus, 
ischemic heart disease, chronic kidney disease, asthma or 
tuberculosis were receiving topical or systemic steroids or 
immunosuppressive agents reported a recent history of a 
cardiovascular or cerebrovascular accident. 
Clinical examination: All patients were subjected to visual acuity 
measurement objectively by auto-refractometer and subjectively by 
Snellen chart and the best corrected visual acuity (BCVA) was recorded 
after Snellen to decimal conversion. 
The patient’s head position and eye position were assessed before 
starting the ocular examination. Extraocular movements were recorded in 
all nine cardinal positions of gaze. This was followed by examination of 
each eye separately. 
The appearance of the upper and lower lid margins, the position of 
both the lids and the interpalpebral fissure height and the lid crease were 
noted. This was followed by a careful examination of the bulbar and 
palpebral conjunctiva and fornices was done.  
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Slit-lamp biomicroscopic examination was done for all patients. The 
status of all the corneal layers, namely the epithelium, stroma and 
endothelium, was noted. The presence of guttae, keratic precipitates, 
pseudoexfoliative material and pigments on the corneal endothelium was 
recorded. 
The central and peripheral anterior chamber depth was assessed 
using Shaffers system of grading of anterior chamber depth. The presence 
of flare or cells was also looked for in the anterior chamber. 
The colour and pattern of the iris, and the presence of peripheral 
anterior synechiae, iris atrophic patches, or pre-existing surgical or non-
surgical peripheral iridotomy wounds were noted. The pupillary size, 
shape, regularity, presence of synechiae, reaction to direct and consensual 
light reflex and presence of pseudoexfoliative material along the papillary 
ruff were also noted. 
In cases of mature cataract, the macular function was assessed by the 
presence of a normal pupillary reaction and the absence of any relative 
afferent pupillary defect (RAPD). 
Assessment of lenticular status: The lenticular status was assessed using 
the Lens Opacification Classification System (LOCS III) (Chylack et al., 
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1993)64. The LOCS III contains an expanded set of standards (Fig. 1) 
selected from the Longitudinal Study of Cataract slide  library at the 
Center for Clinical Cataract Research (Boston, MA, United States of 
America). It consists of six slit lamp images for grading nuclear colour 
(NC) and five retroillumination images for grading posterior subcapsular 
cataract (PSCC) (Fig. 1). 
Nuclear cataract was graded by comparing the colour of the lens to 
be graded with the standard colour photographs defined by the LOCS III as 
NC grades 1 to 6.While grading nuclear colour, two regions of the nucleus, 
namely, the entire cross-sectional view of the nucleus and the posterior 
subcapsular reflex, were viewed.  
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Figure 1. Slit- lamp images for grading nuclear colour and 
retroillumination images for grading posterior subcapsular cataract in the 
Lens Opacities Classification System III.From: Chylack LT Jr. et al. Lens 
Opacities Classification System III [LOCS III]. Arch Ophthalmol 1993; 
111: 831-836. (Reproduced with permission from the American Medical 
Association, License No. 3286581148272 dated December 12, 2013).  
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 This grading is different from that followed in LOCS II in that the 
colour of the entire nucleus is considered, in addition to the posterior 
reflex. This method thus avoids overestimation of the brunescent stage, 
which occurs occasionally when the reflex alone is used. 
Posterior subcapsular cataracts were graded by using only 
posteriorly focused retro-illumination images.The area of the opacity in the 
lens being graded was compared with the standards 1 to 5.The posterior 
segment status was assessed using the slit-lamp and a 90D lens.In patients 
in whom there was no view of the posterior segment, ultrasound B-Scan 
was done to exclude any underlying ocular pathology. 
Pre-operative workup: The patency of the nasolacrimal duct was 
assessed. 
Keratometry was performed on both eyes manually with a Super 
KMS-6™ keratometer, (Bausch and Lomb, USA) and with an automated 
keratometer (KM-500 NIDEK™) Autokeratometer, and the average 
keratometry reading was then calculated. 
Intraocular lens (IOL)power calculation was done by a non-contact 
method using the IOL Master 500 (Carl Zeiss Medite AG); in patients with 
more dense cataracts that totally obscured media clarity, a contact method, 
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using the immersion technique using the Ocuscan ™ P/N 683-3001-505 
(Alcon Surgicals, USA) was resorted to. The SRK-II formula (A-2.5L-
0.9K) was used to calculate IOL power, taking into account the axial 
length (L) and average keratometry (K) reading. ‘A’ constant was 
calculated as provided by the manufacturer. 
Pre-operative preparations: On the day of surgery, a thorough 
preoperative assessment of the patient was performed. This was followed 
by pre-operative preparation of the patient. The patients were instructed to 
wash their face with soap and water. Appropriate head and foot gear were 
provided before entry into the operation theatre complex. The skin around 
the eye was cleaned with povidone-iodine 5%. Following this, peribulbar 
block was given to the eye to be operated. This was again followed by 
cleaning of the conjunctival cul de sac and the skin around the eye with 
povidone iodine. 
Operative techniques 
Surgery (both SICS and phacoemulsification) was performed under 
the magnification of an operating microscope (Leica Microsystem™ 
Model M220F12, Singapore; Carl Zeiss S88 OPMI Lumere T ™ Model 
302608-9020-000, Carl Zeiss Surgical GmbH, Oberkochen, Germany). 
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In patients undergoing SICS65, following conjunctival peritomy, 
bleeders were cauterized.The expected size and density of the nucleus 
determined the size of the tunnel, with the extraction of earlier stages of 
nuclear cataracts requiring only a small tunnel (sufficient for the IOL optic 
to pass through) while very big, brown nuclei required a larger tunnel size. 
A 3 plane sclerocorneal tunnel incision extending at least 1 to 2 mm into 
the clear cornea was made. Following continuous curvilinear 
capsulorhexis, hydrodissection was performed, followed by use of a vectis 
or viscoexpression. A 360 degree cortex aspiration was done using a 
Simcoe cannula, followed by placement of the posterior chamber IOL.  
  In the phacoemulsification technique 66,67,68, the same pre-operative 
protocol for patient preparation was followed. After conjunctival peritomy, 
a 5 mm corneo-scleral tunnel incision was made. Continuous curvilinear 
capsulorrhexis not exceeding 5mm was also performed. The phaco probe 
(an ultrasonic handpiece with a titanium or steel needle) was used 
(Millenium ™ Ref CX6200 S721305, Bausch and Lomb Inc., Rochester, 
NY, USA; Alcon Infiniti Ozil™. Vision System, Alcon Laboratories, 
USA; Megatron Gender AG™, Heidelberg, Germany). The tip of the 
needle vibrated at an ultrasonic frequency to sculpt and emulsify the 
cataract while the pump aspirated particles through the tip. A second fine 
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steel instrument, called a "chopper", was used from a side port to help with 
chopping the nucleus into smaller pieces. Either a `stop and chop’ 
technique or a `divide and conquer’ technique was followed to break the 
nucleus. Thus, the cataract was broken into two or four pieces and each 
piece was emulsified and aspirated out  with suction. After removing all 
hard central lenticular nuclear pieces by phacoemulsification, the softer 
outer lens cortex was removed by suction only. An irrigation-aspiration 
probe or a bimanual system was used to aspirate out the remaining 
peripheral cortical matter, while leaving the posterior capsule intact.  
An IOL was placed in the capsular bag. For implanting a 
polymethylmethacrylate IOL, the incision had to be enlarged while this 
was not necessary to implant a foldable IOL.  
All patients were examined the day after surgery as a routine post-
operative day one follow-up. The status of the cornea was noted and 
presence of striate keratopathy, Descemet’s membrane folds, Descemet’s 
membrane stripping, and epithelial or stromal edema was also noted. The 
anterior chamber was examined for presence of excessive flare or cells, 
hyphema, exudates and hypopyon. The central and peripheral anterior 
chamber depth was also noted. The iris was examined for any surgical 
iridectomy and iris atrophy. The positioning of the posterior chamber IOL, 
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including centration, was noted. The fundus was examined for vitreous 
clarity and presence of any underlying posterior segment pathology. IOP 
was recorded by non contact tonometry. 
  The patients were started on topical corticosteroids for hourly use 
and were advised to come for followup after one week. At the follow-up 
visit, the patient’s uncorrected visual acuity was measured. The anterior 
segment was evaluated for presence of corneal edema, flare and cells. The 
posterior chamber IOL position and centration were noted. 
BIOCHEMICAL STUDIES 
 These were performed on representative cataractous lenses from 
patients undergoing cataract surgery, and on transparent lenses obtained 
during eye donation.  
Sodium-Dodecyl-Sulfate Polyacrylamide Gel Electrophoresis (SDS-
PAGE) analysis of total lenticular protein (soluble and insoluble 
fractions) pattern : The total soluble and insoluble protein pattern was 
analyzed by subjecting the sample to 4-20% gradient SDS-PAGE 
following the method of Laemmli (1970)69. The gradient was prepared 
using 60% sucrose along with 30% acrylamide, Tris buffer, ammonium 
persulphate (APS) and N, N, N', N'-tetramethylethylenediamine (TEMED). 
Two different percentages (4% and 20%) of separating gel solutions were 
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constituted and the gradient was prepared by mixing these two solutions 
using a gradient mixer. The mixed solution was poured into a sealed glass 
plate setup (8 cm high and 1.5 mm thick) for polymerization. After the 
polymerization was complete, the 3% stacking gel was poured over the 
separating gel and a Teflon comb was inserted to form wells. Later, the 
Teflon comb was removed and the wells were rinsed with distilled water. 
The basal strip was then removed and the glass plate with polymerized gel 
was fixed to the electrophoretic  apparatus. When the setup was ready, the 
samples were mixed with equal amounts of gel-loading dye and loaded 
into the well. Electrophoretic separation was allowed for 180 minutes at a 
constant voltage of 50V for the stacking gel and 100V for the separating 
gel. The electrode solution used was 25 mM Tris, 0.193 M glycine buffer 
containing 0.1% SDS. Broad range  protein markers were simultaneously 
run for comparison. The gel was stained using Coomassie Brilliant Blue R-
250 and destained with 7% acetic acid and 40% ethanol. The bands that 
developed, after staining and destaining, were scanned in a gel 
documentation system (Bio-Rad, USA) to determine the intensity of the 
bands. The concentration of proteins in each band was determined from the 
standard graph plotted against the intensities of the bands corresponding to 
the known standard marker proteins. The program Quantity One SW (Bio-
Rad, USA) was used for the analysis of intensity of bands in each lane of 
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the gels. Density profiles of each lane of the gels were used to calculate the 
peak intensity of the selected protein bands corresponding to soluble and 
insoluble proteins.  
Two dimensional (2D) gel electrophoresis analysis of the pattern of 
total lenticular protein (soluble and insoluble fractions): Four lenses 
from each group were homogenized in 200 mL lysis solution containing 
protease inhibitors, followed by centrifugation, as described earlier. The 
supernatant containing the soluble protein was removed, and the pellet 
(insoluble protein) was washed twice with homogenizing buffer. The 
insoluble protein was then resuspended in 8M Urea, and the protein 
content in both the soluble and insoluble fractions were measured by the  
 Bradford method (1976)70, using bovine serum albumin as a 
standard. Both fractions of lens proteins were aliquoted into 400-mg 
portions and stored at -70°C.  
Immobilized pH gradient (IPG) strips (linear pH 5-8, 7 cm) (Bio-
Rad, USA) were rehydrated overnight with 160 μg of total protein derived 
from individual subjects as mentioned above and premixed with a 
rehydration buffer. The first-dimensional separation was performed  
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in Protean IEF Cell (Bio-Rad, USA) at 20°C, using stepwise mode to reach 
10,000 Vh. After completion of the isoelectric focusing, the separated 
proteins were equilibrated with another buffer for a further 15 min. The 
equilibrated IPG strips were then transferred onto 12% acrylamide slab 
gels (8 × 9.5 cm) and the second-dimensional separation was performed in 
Mini-Protean Tetra Cell (Bio-Rad, USA) with the current of 200 v/gel for 
approximately 40 min. The resolved protein spots were then visualized 
using Coomassie Brilliant Blue R-250 stain.  
PD Quest (Bio-Rad), was used for matching and analysis of protein 
spots on 2-D gels. A reference gel was created by combining into one 
image all of the spots that had appeared in the individual gels. The 
reference gel was then used for matching of corresponding protein spots 
among different gels. Background subtraction was performed and the 
intensity volume of each spot was normalized with the total intensity 
volume (summation of the intensity volumes obtained from all spots within 
the same 2-D gel). Protein spots of particular interest, based on pI and 
MW, were excised with a clean scalpel, and processed according to the 
method described by Courchesne and Patterson (1999)71. 85 Peptides were 
directly spotted into the matrix-assisted laser desorption/ionization 
(MALDI) plate with 10 mg/mL α-cyano-4-hydroxycinnamic acid  50% 
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acetonitrile and 0.1% (v/v) TFA, and the spots were allowed to dry 
completely. Mass spectra of positively-charged ions were recorded on an 
Ultraflex MALDI TOF mass spectrometer (Bruker Daltonik) under the 
control of FlexControlTM 2.2 software (Bruker Daltonik GmbH). 
Statistical Analysis  
 SPSS™ statistical software version 16 (Statistical Package for the 
Social Sciences for MS Windows, SPSS Inc., Chicago, IL, USA) and 
Microsoft 2007 Office Excel™ software were used for statistical 
calculations. Differences in age, mean visual acuity and other continuous 
variables were calculated by independent sample Student `t’tests. Yates’s 
corrected chi-square tests were used to analyse differences between 
categorical variables, using two by two tables, when appropriate. All 
statistical tests were two-sided (two-tailed), and P ≤ 0.05 was considered to 
be statistically significant.  
  
Results 
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RESULTS 
 
  Clinical aspects of the present dissertation were studied in patients 
presenting with diminished vision due to lenticular opacification at the 
Institute of Ophthalmology, Joseph Eye Hospital, Tiruchirapalli, 
Tamilnadu, over a period of 11 months (December 1, 2011 to October 31, 
2012). Biochemical aspects were studied concurrently. Clinical and 
biochemical data were analysed and interpreted subsequently (March 2013 
to September 2013).  
 1.  CLINICAL ASPECTS 
  Over an 11-month period, 604 patients with diminished vision due 
to cataract were seen. Of these, 22 individuals did not provide consent to 
participate while 30 individuals could not be enrolled due to the presence 
of one, or multiple, exclusion criteria. During data analysis, it was found 
that records of an additional 32 patients were incomplete. Hence, analysis 
could be performed for the clinical aspects of the study only on 520 
patients. 
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Using an A-priori sample size calculator for Student `t’ tests, the 
minimum total sample size (two-tailed hypothesis) was calculated to be 
128 while the minimum sample size per group (two-tailed 
hypothesis)was calculated to be 64 (details in Materials and Methods 
section). In actual fact, a total of 520 patients were enrolled in the clinical 
study (130 in the SICS group; 390 in the phacoemulsification group). 
Hence, the requirements for sample size were met in the present study.  
  Patients who were enrolled in the study underwent monoocular 
cataract surgery either by small incision cataract surgery (SICS) or by 
phacoemulsification, as described earlier (Materials and methods). Patients 
who underwent SICS constituted the “SICS group” while those who 
underwent phacoemulsification constituted the “Phaco group”. There were 
130 patients in the SICS group and 390 patients in the Phaco group  
(Table 1). 
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Table 1 :  Age and gender of patients undergoing small incision cataract 
surgery or phacoemulsification  cataract surgery at a tertiary eye 
care hospital 
Gender 
of patient 
Patients undergoing small 
incision cataract surgery 
(SICS group) 
Patients undergoing 
phacoemulsification 
cataract surgery (Phaco 
group) 
Overall 
Total 
Number Mean age ± SD (years) Number 
Mean age ± SD 
(years) 
Males 39 60.95 + 4.44 122 61.66 + 4.61 61 
Females 91 61.97 + 4.82 268 61.56 + 4.33 359 
Group 
total 130  390  520 
Abbreviation:  SD= standard deviation     d.f.= degree of freedom 
Statistical Analysis  
a. Chi-square test (2X2 table) 
b, c, d. & e.  Student ‘t’ test 
a.  Gender distribution in SICS group versus  Phaco group  
 χ2 (d. f. = 1) = 0.048 ; P > 0.05 
b. Mean age of males in SICS group versus  mean age of males in Phaco group 
 ( unpaired) ` t’ (d. f. = 159) =   0.08   ; P= 0.93  
c. Mean age of females in SICS group  versus  mean age of females in Phaco group 
 (unpaired) `t’ (d. f. = 357) =      0.05 ; P= 0.96 
d. Mean age of males versus  mean age of females in SICS group  
 (unpaired) `t’ (d. f. = 128) = 0.13 ; P= 0.9 
e. Mean age of males versus  mean age of females in Phaco group 
 (unpaired) `t’ (d. f. = 388) =  0.01 ; P= 0.99 
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1.1 Age and gender distribution 
 There were 39 males and 91 females in the SICS group and 122 
males and 268 females in the Phaco group (Table 1); these differences 
were not statistically significant (χ2 (degree of freedom [d.f]=1) = 0.05 ;  
p> 0.05). The mean ages of males and females were 60.95 + 4.44 years and 
61.97 + 4.82 years, respectively, in the SICS group and 61.66 + 4.61 years 
and 61.56 + 4.33 years, respectively, in the Phaco group (Table 1); these 
differences were not statistically significant (SICS group males versus 
females, `t’ = 0.13 [d.f. = 128]; p = 0.9 ; Phaco group males versus 
females, `t’ = 0.01 [d.f.=388]; p=0.99; males in SICS versus Phaco groups, 
`t’ = 0.08 [d.f.=159], p=0.93; females in SICS versus phaco groups, 
`t’ = 0.05 [d.f.= 357] p = 0.96). Thus, patients in the SICS group and phaco 
group were, essentially, age-and gender-matched. 
1.2  Co-morbid systemic conditions 
Co-morbid systemic conditions noted in the patients in the two 
groups were hypertension, diabetes mellitus, hypercholesterolemia and 
coronary artery disease (Figure 2).  
  
 Figure 2 :  Presence of
undergoing 
phacoemulsi
hospital  
Abbreviations: d.f.= degre
Statistical Analysis 
a.  Proportions of patient
(60/130 = 46%) versus
1.04 ; P > 0.05 
b.  Proportion of males (7
total 359 females) with
P = 0.03 
c.  Proportions of males (
total 359 females) with
d.  Proportions of males (1
total 359 females) with
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1.2.1  In SICS group versus Phacoemulsification group 
Overall, co-morbid conditions occurred in 60 (46%) of 130 patients 
in the SICS group and in 158 (40.5%) of 390 patients in the Phaco group 
(Figure 2); this difference was not statistically significant (χ2 [d.f.=1]=1.04; 
p > 0.05). Hypertension was, by far, the most frequent co-morbid condition 
in males in both groups, affecting 57% in the SICS group and 47% in the 
phaco group (Figure 2). 
1.2.2.  In Males versus Females 
Interestingly, co-morbid conditions occurred significantly more 
frequently in males (78 [48.4 %] of 161) than in females (140 [39%] of 
359) studied (χ2 [d.f.=1] = 4.47 ; P = 0.03) (Figure 2). Hypertension and 
diabetes mellitus were the most frequent co-morbid conditions in females 
in both groups, affecting 41% and 36%, respectively, in the SICs group, 
and 43% and 35%, respectively, in the Phaco group (Figure 2). 
Interestingly, hypertension was seen significantly more frequently in males 
(39 [24%] of 161 males) than in females (59 [16.4%] of 359 females) in 
the current study (χ2 [d.f.=1] = 4.4 ; P=0.04). Although diabetes mellitus 
occurred more frequently in females (49 [13.6%] of 359) than in males (17 
[10.6%] of 161), this difference was not statistically significant (χ2 [d.f.=1] 
= 0.96; P=0.33). 
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1.3  Types of cataracts 
Various grades of nuclear (Figures 3, 4 and 5), posterior subcapsular 
(Figures 7, 8 and 9) and end-stage cortical (mature and hypermature) 
cataracts (Figures 10 and 11) were seen in the patients. These cataracts 
were graded according to the LOCS classification III (Fig.1 in Materials 
and Methods section); these details are listed in Table 2 and Figures 6, 12 
and 13.  
1.3.1  In SICS group versus Phacoemulsification group 
In the SICS group (total 130 patients), three patients (2%) had NC2, 
52 (40%) had NC3, 38 (29%) had NC4, eight (6%) had NC5 and 29 (23%) 
had mature / hypermature cataracts ; corresponding percentages in the 
Phaco group (total 390 patients) were 2%, 30%, 34%, 8% and 26%, 
respectively (Table 2). These differences were not statistically significant 
(χ2 [d.f.=4]=4.8 ; P=0.31).  
Sixty-six (12.7%) of 520 patients in the current study suffered from 
diabetes mellitus.   
The percentage of diabetics in SICS group with posterior 
subcapsular cataracts was 50%.  
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Table 2:  Grades of  cataracts in patients undergoing small incision cataract 
surgery or phacoemulsification cataract surgery at a tertiary eye 
care hospital  
Grades of 
nuclear cataract 
(LOCS 
classification) 
 
In small incision cataract surgery 
(SICS) group 
In phacoemulsification cataract 
surgery(Phaco) group 
Overall 
Total 
Males Females Sub total (%)* Males Females 
Sub total 
(%)* 
NC 2 0 3 3 ( 2%) 1 7 8 ( 2%) 11 
NC 3 18 34 52(40%) 41 76 117(30%) 169 
NC 4 10 28 38(29%) 32 100 132(34%) 170 
NC 5 1 7 8 (6%) 9 24 33( 8%) 41 
MC / HMC 10 19 29(23%) 39 61 100(26%) 129 
Group Total 39 91 130(100%) 122 268 390(100%) 520 
 
* Percentage of group total 
 
Abbreviations: LOCS =Lens Opacities Classification System III 
 NC= nuclear cataract ; MC/HMC= mature cataract/hypermature cataract 
 
Statistical Analysis 
a.  Proportions of patients with different grades of cataracts in SICS group 
versus(vs.)  Phaco group: χ2 (d. f. = 4) = 4.8 ; P =0.31 
b.  Proportions of males vs. females with different grades of cataracts: 
χ2 (d. f. = 4) = 10.6;  P= 0.03 ; Yates’ corrected χ2 (d. f. = 4) = 8.63;  P= 0.07  
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NUCLEAR CATARACT GRADE 2 
 
 (a)       (b) 
  
 
    (C) 
    
 
Figure 3.  Anterior segment photographs of the right eye showing Grade 2 
nuclear cataract 
(a) – on diffuse illumination (8X magnification) 
(b) – with stereoscopic slit beam illumination 
(c) – on retroillumination with slit 
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NUCLEAR CATARACT GRADE 3 
 
 (a)        (b) 
  
 
   (c) 
      
 
Figure 4.  Anterior segment photographs of the right eye showing Grade 3 
nuclear cataract 
(a) – on diffuse illumination (8X magnification) 
(b) – with Stereoscopic slit beam illumination 
(c) – on retroillumination  
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NUCLEAR CATARACT GRADE 4 
 
 (a)       (b) 
  
 
 
   (c) 
    
 
Figure 5.  Anterior segment photographs of the right eye showing Grade 4 
nuclear cataract 
(a) – on diffuse illumination (8X magnification) 
(b) – on diffuse illumination (12X magnification)  
(c) – on slit beam illumination  
  
  
 
Figure 6.  Occurrence o
diabetes melli
phacoemulsific
Percentage of diabetics in 
Percentage of diabetics 
cataracts= 50% 
Percentage of diabetics 
cataracts=47.9% 
Posterior subcapsular cata
43.9%, in the current study
 
 
  
0
5
10
15
20
25
SICS
6
51 
f posterior subcapsular cataracts in pat
tus undergoing small incision cataract s
ation cataract surgery at a tertiary eye care
this study :  66 out of 520 = 12.7% 
in SICS group with posterior su
in Phaco group with posterior su
racts occurred in 23 out of total 66 d
 
PSCC present
PSCC abse
Phaco
23
12
25
PSCC p
PSCC a
ients with
urgery or 
 hospital.  
 
bcapsular
bcapsular
iabetics= 
nt
resent
bsent
52 
 
POSTERIOR SUBCAPSULAR CATARACT GRADE 1  
 
 
 (a)       (b) 
  
 
   (c) 
    
 
 
Figure 7.  Anterior segment photographs of the right eye showing posterior 
subcapsular cataract Grade 1 on 
(a) – Diffuse illumination (8X magnification) 
(b) – Slit beam illumination  
(c) – on retroillumination  
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POSTERIOR SUBCAPSULAR CATARACT GRADE 2 
 
 (a)       (b) 
  
 
 
    (c) 
    
 
 
 
Figure 8.  Anterior segment photographs of the right eye showing posterior 
subcapsular cataract Grade 2 on 
(a) – Diffuse illumination (8X magnification) 
(b) – on Slit beam illumination  
(c) – on retroillumination  
 
54 
 
POSTERIOR SUBCAPSULAR CATARACT GRADE 3 
 
 (a)       (b) 
  
 
 
   (c) 
    
 
 
Figure 9.  Anterior segment photographs of the right eye showing posterior 
subcapsular cataract Grade 3 on 
(a) – Diffuse illumination (8X magnification) 
(b) – on Slit beam illumination  
(c) – on retroillumination  
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MATURE CATARACT 
 
 (a)       (b) 
  
 
 
   (c) 
    
 
Figure 10.  Anterior segment photographs of the left eye showing mature 
cataract on 
(a) – Diffuse illumination (8X magnification) 
(b) – Diffuse illumination (12X magnification) 
(c) – on Slit beam illumination  
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HYPERMATURE CATARACT 
 (a)       (b) 
  
 
 
   (c) 
   ( 
 
Figure 11.  Anterior segment photographs of the right eye showing 
hypermature cataract (sclerotic type) on 
(a) – Diffuse illumination (8X magnification) 
(b) – Diffuse illumination (12X magnification) 
(c) – Slit beam illumination  
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 The percentage of diabetics in the Phaco group with posterior 
subcapsular cataracts was 47.9%. Posterior subcapsular cataracts occurred 
in 23 out of total 66 diabetics= 43.9%, in the current study (Fig. 6). 
In the SICS group (total 130 patients), 54 patients (41.5 %) had 
different grades of posterior subcapsular cataract (PSSC) in association 
with nuclear cataract (Fig.11); 29 had PSSC1, 21 had PSSC 2 and six had 
PSSC 3. In the Phaco group (total 390 patients), 195 (50%) had PSSC 
cataracts in association with nuclear cataracts (Fig. 12); 95 had PSSC 1, 78 
had PSSC 2 and 21 had PSSC 3 (Fig. 12). These differences were not 
statistically significant (χ2 with Yates’ correction [d.f.=1]=2.5 ; P=0.11).  
1.3. 2  In Males versus Females  
In males, NC2 cataracts were noted in 0.4 %, NC3 cataracts in 37%, 
NC4 cataracts in 26%, NC5 cataracts in 6.2% and mature / hypermature 
cataracts in 30.4% ; in female  patients, the percentages were 3%, 31%, 
35%, 9% and 22%, respectively. Interestingly, these gender differences 
approached statistical significance (χ2 [d.f.=4] = 10.6, P = 0.03 : with 
Yates’ correction, χ2 = 8.63, P = 0.07) (Table 2). 
PSSC cataracts were noted (in association with nuclear cataracts) in 
71 males and 179 females (Figures 11 and 12). In males, PSSC 1 cataracts 
were seen in 33 (46.5% of 71 males), PSSC 2 was seen in 30 (42.3 %) and 
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PSSC 3 in eight (11.2% of 71 males); in females the corresponding 
numbers (percentages) were 89 (49.7% of 179 females), 69 (38.5%) and 19 
(10.6% of 179 females (Fig. 11 and 12). These differences were not 
statistically significant (χ2 with Yates’ correction [d.f.=1] = 1.26, 
P = 0.26).  
1.4  Pre-operative and post-operative visual acuity  
  In the 130 patients who had undergone SICS, the post-operative 
mean visual acuity (decimals), 0.58 + 0.02, was significantly better than 
the pre-operative mean visual acuity of 0.07 + 0.01 (unpaired `t’ [d.f.=258] 
= 21.6 ; P < 0.0001) (Table 3). This significant improvement was seen in 
both males and females (Table 3).  
Similarly, in the 390 patients who underwent phacoemulsification 
surgery, the post-operative mean visual acuity (0.64 + 0.01) was 
significantly better than the pre-operative mean visual acuity of 0.07 + 
0.01 (unpaired `t’ [d.f.= 776) = 38.7 ; P < 0.0001) (Table 4). This 
significant improvement was seen in both males and females (Table 4). 
  A comparison was made of the visual acuity results obtained in the 
SICS and Phaco groups (Tables 3 & 4). With reference to mean pre-
operative visual acuities (decimal units), no significant differences 
between the groups were observed when total patients (SICS [ 0.07 + 0.01] 
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versus Phaco [0.07 + 0.01] ; t = 0.28 [d.f.=519, P = 0.78), males (SICS 
[0.08 + 0.01] versus Phaco [0.06 + 0.01]; t = 1.25 [d.f. = 159], P=0.21) or 
females (SICS [0.07 + 0.01] versus Phaco [0.07 + 0.01]) were compared. 
However, when post-operative mean visual  acuities (decimal units) were 
analysed and compared, the following interesting observations emerged 
(Tables 3 & 4):  
a)  there was no significant difference between the post-operative mean 
visual acuity in the SICS and Phaco groups in males (SICS [0.67 + 
0.04] versus Phaco [0.63 + 0.03]; t = 0.88 (d.f.=159), P = 0.38);  
b)  in females, the post-operative mean visual acuity in the Phaco group 
[0.64 + 0.02] was significantly higher (better) than that in the SICS 
group [ 0.55 + 0.03] (t = 2.79 [d.f.=357] ; P = 0.0055). 
c)  When all patients were considered, the post-operative mean visual 
acuity in the Phaco group (0.64 + 0.01) was higher (better) than that 
in the SICS group [0.58 + 0.02], and this difference approached 
statistical significance (t=1.86 [d.f.=518] ; P = 0.06). 
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Table 3 :  Mean pre-operative and mean post-operative visual acuity in 
patients undergoing small incision cataract surgery at a tertiary eye 
care hospital  
Gender 
of 
patients 
Number of 
patients 
Mean (+ SEM) visual acuity 
(decimals) Statistical Analysis 
(Student `t’[paired]) 
Pre-operative Post-operative 
Male 39 0.08 + 0.01 0.67 + 0.04 
t = 12.6 (d. f.=38); 
P < 0.0001 
Female 91 0.07 + 0.01 0.55 + 0.03 
t= 17.8 (d. f.=90); 
P < 0.0001 
All 130 0.07 + 0.01 0.58 + 0.02 
t = 21.6 (d. f.=129); 
P < 0.0001 
Statistical 
Analysis(Student `t’ 
[unpaired]) 
Males versus Females 
t=0.82 
(d.f.=128) 
P=0.42 
t=2.52 (d.f.=128) 
P=0.01 
 
 
Abbreviation     SEM = Standard error of mean, d.f.= degree of freedom 
 
Table 4 :  Mean pre-operative and mean post-operative visual acuity in 
patients  undergoing phacoemulsification cataract surgery at a 
tertiary eye care hospital  
Gender 
of 
patients 
Number of 
patients 
Mean + SEM visual acuity 
(decimals) Statistical Analysis 
(Student `t’[paired]) 
Pre-operative Post-operative 
Males 122 0.06 + 0.01 0.63 + 0.03 
t = 20.7 (d. f.=121); 
P < 0.001 
Females 268 0.07 + 0.01 0.64 + 0.02 
t= 33.1 (d. f.=267); 
P < 0.0001 
All 390 0.07 + 0.01 0.64 + 0.01 
t = 38.74 (d. f.=389); 
P < 0.0001 
Statistical Analysis 
(Student ‘t’[unpaired]) 
Males versus Females 
t=1.03 (d.f.=388) 
P=0.30 
t=0.41 (d.f.=388) 
P=0.68 
 
 
Abbreviation     SEM = Standard error of mean, d.f.= degree of freedom 
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1.5  Surgical and post-operative complications, pre-existing 
pathology and combined surgery 
 The frequency of surgical and post-operative complications, pre-
existing pathology and combined surgery was compared between the SICS 
and Phaco groups (Table 5). Complications were encountered in five (4%) 
of 130 patients in the SICS group and 17 (4.3%) of 390 patients in the 
Phaco group, this difference was not statistically significant (χ2 [d.f.=1] = 
0.06 ; P = 0.8) (Table 5). Pre-existing pathology was present in six (4.6%) 
of 130 SICS group patients and nine (2.3%) of 390 Phaco group patients 
(Table 5). This difference was not statistically significant (χ2 [d.f.=1] =1.9; 
P = 0.17). Combined surgery was needed for 13 (10.0 %) of 130 SICS 
group patients and 17 (4.4 %) of 390 phaco group patients (Table 5); this 
difference was statistically significant (χ2 with Yates’ correction [d.f.=1] = 
4.72 ; P=0.03).  
When differences between males and females in frequency of 
occurrence of these parameters were compared, no statistically significant 
differences were observed, except within the Phaco group, where pre-
existing pathology was present in six (5%) of 122 males and three (1.1%) 
of 268 females (Yates’ χ2 (d.f.=1) = 3.81 ; P = 0.05). 
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Table 5:  Complications, pre-existing pathology and combined surgery in 
small incision or phacoemulsification cataract surgery at a tertiary 
eye care hospital 
Parameter 
In small incision cataract 
surgery (SICS) group 
(total n = 130) 
In phacoemulsification 
cataract surgery 
(Phaco)group(total n= 390) Overall 
Total 
Males Females Sub total Males Females 
Sub 
total 
Surgical 
complications 
2 
 
3 5 7 10 
 
17 
 
22 
Pre-existing 
pathology 2 4 
 
6 
6 3 
 
9 
 
15 
Combined 
surgery 4 9 
 
13 
5 12 
 
17 
 
30 
Group total 8 16 
 
24 
18 25 
 
43 
 
67 
 
Statistical Analysis (Chi-square with Yates’ correction) 
a)  Combined surgery needed for 13 (10.0 %) of 130 SICS group  patients and 17 
(4.4 %) of 390 phaco group patients; χ2 with Yates’ correction [d.f.=1] = 4.72 ; 
P=0.03.  
b)  Phacogroup ; Pre-existing pathology in 6 of 122 males and 3 of 268 females   
χ2 (d. f. = 1) = 3.81 ; P = 0.05 
  
65 
1.6  Post-operative visual outcome in relation to pre-operative 
cataract grade 
1.6.1  In SICS group versus Phacoemulsification group 
Different degrees of post-operative (PO) visual acuity (Snellen’s 
units) in relation to pre-operative cataract grade were compared in patients 
who had undergone SICS and in those who had undergone 
phacoemulsification cataract surgery (Table 6). Of three patients in the 
SICS group who had had preoperative NC2 cataracts, two achieved PO 
visual acuity of 6/9 and one achieved 6/12, while of eight patients in the 
Phaco group who had had preoperative NC2 cataracts, two each achieved 
PO visual acuities of 6/6, 6/9, 6/12 and ≥ 6/24 (Table 6). 
 Fifty-one patients in the SICS group who had had preoperative NC3 
grade cataracts achieved PO visual acuities of 6/6 (13 [25.5%] of 51 
patients), 6/9 (21 [41.2%]), 6/12 (seven [13.2%]), 6/18 (four [7.8%]) and 
6/24 or worse (six [11.8%] of 51 patients) whereas 117 patients in the 
Phaco group who had had preoperative NC3 grade cataracts achieved PO 
visual acuities of 6/6 (30 [25.6%] of 117 patients), 6/9 (51 [43.6%]), 6/12 
(14 [11.97%]), 6/18 (eight [6.8%]) and 6/24 or worse (six [11.97%] of 117 
patients) (Table 6); these differences were not statistically significant  
(χ2 [d.f.=4]=0.19; P=0.99).  
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Table 6:  Post-operative visual acuity versus preoperative nuclear cataract 
grades* in small incision or  phacoemulsification cataract surgery at 
a tertiary eye hospital. 
Grade of 
nuclear 
cataract 
(LOCS) 
Post-operative (PO)visual acuity (Snellen) PO visual acuity(Snellen) Phaco group (total 
no. = 390) Overall 
Total 
SICS group (total no. = 130) 
6/6 6/9 6/12 6/18 
≥ 
6/24 
 
Group 
total 6/6 6/9 6/12 6/18 
≥6/24 
 
Group 
total 
NC 2 - 2 1 - - 3 2 2 2 - 2 8 11 
NC 3 13 21 7 4 6 51 30 51 14 8 14 117 168 
NC 4 8 14 8 5 3 38 41 45 20 10 16 132 170 
NC 5 1 3 1 1 2 8 11 8 7 2 5 33 41 
MC/ 
HMC 4 9 9 2 6 30 28 41 11 11 9 100 130 
Group 
total 26 49 26 12 17 130 112 147 54 31 46 390 520 
Abbreviations: LOCS= Lens Opacities Classification System; no. = number; SICS = 
small incision cataract surgery; NC=nuclear cataract; MC/HMC= mature/hypermature 
cataract;  
Statistical Analysis (χ2 [degree of freedom {d.f.}= 4] with Yates’ correction where 
necessary) 
1. NC 2 cataract : No. of patients in SICS group vs.  Phaco  group with PO visual 
acuities (statistical analysis not done) 
2. NC 3 cataract : No. of patients in SICS group vs.  Phaco  group with PO visual 
acuities;  χ2 = 0.19; P= 0.99 
3. NC 4 cataract : No. of patients in SICS group vs.  Phaco  group with PO visual 
acuities; χ2 = 3.23; P= 0.5 
4. NC 5 cataract: No. of patients in SICS group vs.  Phaco  group with PO visual 
acuities; χ2 = 2.36; P= 0.67 
5. MC/HMC cataract: No. of patients in SICS group vs.  Phaco  group with 
PO visual acuities 6/6 and 6/9 vs. ≥ 6/12. Yates’ χ2 (d.f.=1)=5.47  P= 0.02 
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Thirty-eight patients in the SICS group who had had preoperative 
NC4 grade cataracts achieved PO visual acuities of 6/6 (eight [21%] of 38 
patients), 6/9 (14 [36.8%]), 6/12 (eight [21%]), 6/18 (five [13.2 %]) and 
6/24 or worse (three [8%] of 38 patients) whereas 132 patients in the Phaco 
group who had had preoperative NC4 grade cataracts achieved PO visual 
acuities of 6/6 (41 [31.1%] of 132 patients), 6/9 (45 [34.1%]), 6/12 (20 
[15.2%]), 6/18 (10 [7.6 %]) and 6/24 or worse (16 [12 %] of 132 patients) 
(Table 6); these differences were not statistically significant (χ2 
[d.f.=4]=3.23; P=0.5). Similarly, of eight patients in the SICS group and 33 
patients in the Phaco group who had had preoperative NC5 grade cataracts, 
the PO visual acuities achieved were 6/6 (in one of 8 [SICS] and 11 
[33.3%] of 33 Phaco group patients), 6/9 (in three [37.5%] SICS patients 
and in eight [24.2%] Phaco patients), 6/12 (in one of eight [SICS] and in 
seven [21.2%] of 33 Phaco group patients), 6/18 (in one of eight [SICS] 
and in two [6.1%] of 33 Phaco group patients) and 6/24 or worse (in two 
[25%] of eight patients [SICS] and in five [15.2%] of 33 [Phaco group] 
patients) (Table 6); these differences were not statistically significant (χ2 
[d.f.=4]=2.36; P=0.67).  
Interestingly, significant differences between the SICS and Phaco 
groups were observed when PO visual acuities were assessed against pre-
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operative mature and hypermature cataract grades (Table 6). In the Phaco 
group, of 100 individuals who exhibited preoperative mature or 
hypermature cataracts, 69 (69%) achieved PO visual acuities of 6/6 or 6/9 
while 31 (31%) achieved PO visual acuities of 6/12, 6/18 or 6/24 and 
worse ; in contrast, in the SICS group, of 30 individuals who had had 
preoperative mature or hypermature cataracts, 13 (43.3%) achieved PO 
visual acuities of 6/6 or 6/9 while 17 (56.7%) achieved PO visual acuities 
of 6/12 or worse (Table 6). This difference was statistically significant (χ2 
[d.f.=1]=5.47; P=0.02).  
1.6.2  In males versus females  
Different degrees of PO visual acuity (Snellen’s units) were also 
assessed in relation to pre-operative cataract grade from another viewpoint, 
that is, gender of the patients (Table 7). Interestingly, significant 
differences between males and females were observed when PO  visual 
acuities were assessed against pre-operative NC3 cataract grade (Table 7). 
Of 58 males who had had preoperative NC3 grade cataracts, 24 (41.4 %) 
achieved a PO visual acuity of 6/6, 13 (22.4 %) achieved 6/9, 12 (20.7 %) 
achieved 6/12, four (6.9 %) achieved 6/18 and five (8.6%) achieved a PO 
visual acuity of 6/24 or worse; in contrast, of 110 females who had had 
preoperative NC3 grade cataracts, 19 (17.3 %) achieved a PO visual acuity 
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of 6/6, 59 (53.6 %) achieved 6/9, nine (8.2 %) achieved 6/12, eight (7.3 %) 
achieved 6/18 and 15 (13.6%) achieved a PO visual acuity of 6/24 or 
worse (Table 7). These differences were highly statistically significant (χ2 
[d.f.=4]=22.8; P=0.00014).  
With reference to individuals with preoperative NC4 grade cataracts, 
PO visual acuities did not differ significantly between males and females 
(Table 7). With reference to preoperative NC5 grade cataracts in 10 males 
and 31 females, PO visual acuities achieved were 6/6 (in one [10%] of 10 
males and in 11 [35.5 %] of 31 females), 6/9 (in two [20%] of 10 males 
and in nine [29.0 %] of 31 females), 6/12 (in two [20%] males and in six 
[19.4 %] females), 6/18 (in one [10%] of 10 males and in two [6.5%] of 31 
females) and 6/24 or worse (in four [40%] of 10 males and three [9.7%] of 
31 females) (Table 7); these differences approached statistical significance 
(χ2 [d.f.=4]=3.66; P=0.06). With reference to individuals with preoperative 
mature or hypermature grade cataracts, PO visual acuities did not differ 
significantly between males and females (Table 7). 
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Table 7:  Post-operative visual acuity versus different preoperative nuclear 
cataract grades* in males and females undergoing cataract surgery 
at a tertiary eye hospital. 
Grade of 
nuclear 
cataract 
(LOCS) 
Post-operative visual acuity (Snellen) Post-operative visual acuity(Snellen) 
Females (total no. = 390) 
Overall 
Total 
Males (total no. = 161) 
6/6 6/9 6/12 6/18 
≥ 
6/24 
 
Group
total 
6/6 6/9 6/12 6/18 
≥ 
6/24 
 
Group 
total 
NC 2 0 0 0 0 1 1 2 4 3 0 1 10 11 
NC 3 24 13 12 4 5 58 19 59 9 8 15 110 168 
NC 4 16 11 8 3 4 42 33 48 20 12 15 128 170 
NC 5 1 2 2 1 4 10 11 9 6 2 3 31 41 
MC/ 
HMC 
10 18 9 5 8 50 22 32 11 8 7 80 130 
Group 
total 51 44 31 13 22 161 87 152 49 30 41 359 520 
 
Abbreviations: LOCS= Lens Opacities Classification System; no. = number; 
NC=nuclear cataract ; MC/HMC= mature/hypermature cataract; PO=post-operative 
Statistical Analysis (χ2 [degree of freedom {d.f.}= 4] with Yates’ correction where 
necessary) 
1.  NC 2cataract (statistical analysis not done) 
2. NC 3 cataract: No.of males vs. no. of females with PO visual acuities;  
χ2 = 22.8; P= 0.0001 
3. NC 4 cataract : No. of males vs. no. of females with PO visual acuities;  
χ2 = 3.4; P= 0.5 
4. NC 5 cataract: No. of males vs. no. of females with PO visual acuities;  
χ2 = 3.66; P= 0.06 (with Yates’ correction, p=0.1) 
5. MC/HMC cataract: No. of males vs. no. of females with PO visual acuities  
χ2 = 2.6;  P= 0.63 
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1.7  Post-operative first day and post-operative seventh day visual 
acuity  
In the 39 male patients who had undergone SICS, the 7th post-
operative day mean visual acuity (decimals), 0.82 + 0.25, was significantly 
better than the 1st post-operative day mean visual acuity of 0.67 + 0.3 
(paired `t’ [d.f.=38] = 3.9 ; P= 0.0003) (Table 8). In the 91 female patients 
who had undergone SICS, the 7th post-operative day mean visual acuity  
(decimals) of 0.82 + 0.27 was significantly better than the 1st post-
operative day mean visual acuity of 0.54 + 0.24 (paired `t’ [d.f.=90] = 
11.71 ; P < 0.0001) (Table 8).  
Similarly, in the 122 male patients who had undergone 
phacoemulsification cataract  surgery, the 7th post-operative day mean 
visual acuity (decimals) of 0.86 + 0.25, was significantly better than the 1st 
post-operative day mean visual acuity of 0.63 + 0.3 (paired `t’ [d.f.=121] = 
12.3 ; P < 0.0001) (Table 8) while in the 268 females who had undergone 
phacoemulsification cataract surgery, the 7th post-operative day mean 
visual acuity (decimals) of 0.87 + 0.24 was significantly better than the 1st 
post-operative day mean visual acuity of 0.64 + 0.3 (paired `t’ [d.f.=267] = 
18.75 ; P < 0.0001) (Table 8).  
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Table 8:  Mean post-operative 1st day versus mean post-operative 7th day 
visual acuity values in patients  undergoing small incision or 
phacoemulsification cataract surgery at a tertiary eye care hospital  
 
Surgical 
group 
Gender 
of 
patients 
Number 
of 
patients 
Mean + SD visual acuity 
(decimals) at Statistical Analysis 
(Student 
`t’[(paired]) 1
st Post-
operative day 
7th  Post-
operative day 
SICS  Males 
 
  
Females 
39 
 
 
91 
0.67 + 0.3 
 
 
0.54 ± 0.24 
 
 
0.82 + 0.25 
 
 
0.82 ± 0.27 
t = 3.9 (d. f.=38); 
P =0.0003 
 
t = 11.71 (d. f.=90); 
P =<0.0001 
 
Phaco  Males 
 
 
Females 
122 
 
 
268 
0.63 + 0.3 
 
 
0.64 ± 0.3 
0.86 + 0.25 
 
 
0.87 ± 0.24 
t= 12.3 (d. f.=121); 
P < 0.0001 
 
t= 18.75 (d.f.=267); 
P < 0.0001 
Abbreviation SICS= small incision cataract surgery; SD=standard deviation ; d.f.= 
degree of freedom 
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2.  BIOCHEMICAL ASPECTS 
2.1  SDS-PAGE  
 After SDS-PAGE, the gel was imaged and analyzed with 
QuantityOne software. In the normal lens nuclei (Lane N), most proteins 
were 12 to 30 kDa (Fig. 14). In the cataractous lens samples (Lanes S1, S2, 
S3, S4 and S5), the band intensities at ∼20 kDa visibly (P < 0.05) showed 
a gradual reduction in intensity, when compared with the band intensity of 
normal lens nuclei. With increasing nuclear sclerosis (NC2 to NC5 to 
mature/hypermature cataracts, corresponding to lanes S1 to S5), the 
staining intensity of bands corresponding to 29 and 20 kDa proteins was 
found to notably decrease (Fig. 14). In mature/hypermature  cataractous 
lens samples (lane S5), many proteins were found to be missing in the gel, 
when compared to the pattern in normal lenses (lane N). In contrast, the 
distribution of proteins in NC2 cataractous lens samples (lane S1) was 
similar to that obtained in samples from normal lenses (lane N). These 
perceived differences in band staining intensity, as assessed by the naked 
eye, were reinforced by intensity analysis of the SDS-PAGE images using 
computer software.  
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Figure 14 : Sodium dodecyl sulphate polyacrylamide gel 
electrophoretic image of various grades of cataract 
 
 
 
M - protein molecular weight marker 
N - normal human lens (9 bands) 
S1 - human nuclear cataract, Grade 2 (7 bands) 
S2 - human nuclear cataract, Grade 3 (6 bands) 
S3 - human nuclear cataract, Grade 4 (5 bands) 
S4 - human mature cataract  (4 bands) 
S5 - human hypermature cataract (4 bands) 
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2.2  Two dimensional gel electrophoresis 
To further confirm the protein degradation observed on SDS-PAGE, 
two dimensional gel electrophoresis (2-DE) was performed and the gel 
spots corresponding to α-crystallin from the different grades of cataractous 
lenses were selected (Fig. 15). These spots were then subjected to MALDI-
TOF analysis in order to ascertain the crystallin identification (Table 9). 
Alpha-crystallin was identified in all the lens samples, although the 
concentration varied. 
Table 9.  Identification of crystallin protein by mass spectrometry 
(MALDI) 
Protein 
fraction and 
Spot Number 
Crystallin ID 
[Accession 
Number] 
Matched 
masses* 
Number of 
Residues 
covered 
% coverage 
5 (normal 
lens) 
α CRYS 
(P02511) 14 20 51 
7 (cataract 
lens) 
α CRYS 
(P02511) 
12 15 41 
6 (cataract 
lens) 
α CRYS 
(P02511) 
8 38 59 
4 (cataract 
lens) 
α CRYS 
(P02511) 
14 38 73 
7 (cataract 
lens) 
α CRYS 
(P02511) 14 43 82 
6 (cataract 
lens) 
α CRYS 
(P02511) 
13 34 63 
MALDI=Matrix-assisted laser desorption/ionization  
*matched masses included trypsin digestion products with 0-2 missed cuts and partial 
oxidation of methionine. Mass tolerance was 200 ppm. 
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Figure 15 : Two-dimensional gel electrophoretic images of various 
grades of cataract 
 
 
 
Sample 1 - human nuclear cataract, Grade 2 (7 bands) 
Sample 2 - human nuclear cataract, Grade 3 (6 bands) 
Sample 3 - human nuclear cataract, Grade 4 (5 bands) 
Sample 4 - human mature cataract  (4 bands) 
Sample 5 - human hypermature cataract (4 bands) 
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DISCUSSION 
 Cataract continues to be the leading cause of global blindness, 
except in First World countries 72. In 2002, the WHO estimated that 50% of 
global blindness was due to cataract5,6,8. The emerging demographic 
structure of the population worldwide, shows an increasing proportion of 
elderly patients73,74,75. This enhanced life- expectancy in Third World 
countries suggests that the total number of cataract- blind individuals is 
likely to increase. It has been reported to be responsible for 50-80% of 
bilateral blindness76,77. In one study conducted on an older population in a 
rural area of southern India, subjects with age-related cataract had an 
associated decrease in the quality of life and vision function, independent 
of presenting visual acuity in the better eye76,78. Hence it becomes vital to 
tackle cataract which causes potentially reversible visual loss when 
detected early, and thus improve the quality of life in the elderly. 
 Irrespective of its etiology or subtype, cataract remains a condition 
that cannot be alleviated medically. At present, only one approved and 
widely accepted treatment is performed, which involves the surgical 
removal of the cataractous lens and its replacement with an intraocular 
plastic lens72. Cataract surgery itself has been revolutionised over the last 
20 years. The modern day life-style, which dictates the need for excellent 
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vision, has led to increased expectations of best results following cataract 
surgery79. From being a surgical procedure that required long hospital stay, 
with prolonged visual rehabilitation, this has now been transformed into a 
short day-care procedure with immediate, tangible benefits. Although 
cataract surgery is associated with a degree of ocular morbidity, it is now 
possible to offer cataract surgery at an earlier stage of cataract maturation, 
therein sparing patients from an extended period of severe visual 
impairment. It hence becomes mandatory to judge the best time to refer 
and operate on a patient with cataracts 
 The present study is thus an attempt to discern the frequency of 
occurrence of different types of senile cataract (based on the Lens 
Opacification Classification System (LOCS)Version III in patients 
presenting at a tertiary eye care hospital over a defined time period.It also 
aims identify putative correlations between types of senile cataract and 
clinical parameters such as age, gender, presence of systemic diseases 
(such as diabetes mellitus, hypertension and hypercholesterolemia), 
presence of ocular problems (refractive errors, glaucoma). 
 Patients who were enrolled in the study underwent monoocular 
cataract surgery either by SICS (SICS group) or by phacoemulsification 
(Phaco group), as described earlier. There were 130 patients in SICS group 
and 390 patients in the Phaco group. Interestingly, the number of females 
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undergoing cataract surgery (91 in SICS group, 268 in Phaco group) 
exceeded the number of males (39 in SICS and 122 in Phaco groups). 
Although this difference was not statistically significant, it was consistent 
with the results of an Australian study (Blue Mountain Eye Study) in 
which the 10-year incidence of cataract was significantly higher in women 
than in men 80. The Aravind Comprehensive Eye study (Nirmalan PK et 
al., 2004)77  reported a significantly lower prevalence of cataract (age-
adjusted) in males. 
 A meta-analysis of cataract surveys in Third World countries 
reported that the cataract surgical coverage rate in the population was 
approximately 1.5 times higher for males than for females 81. In spite of the 
lower cataract surgical coverage rate, 63% of all cataract surgeries were 
done in females; had females received cataract surgery at the same rate as 
males, cataract blindness prevalence would be reduced by a median of 
12.5%82. Cataract extractions may be performed more frequently in women 
than in men, by a 2:1 ratio83,84, since women apparently live longer 85 , or 
due to a higher prevalence of cataract in women86  or because men tolerate 
a larger visual loss than women before they request surgery 86,87.  
 The mean ages of patients enrolled in this study was, 60.95 + 4.44 
years in males and 61.97 + 4.82 years in females in the SICS group. In the 
phaco group, the mean age of male patients was 61.66 + 4.61 years and 
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females 61.56 + 4.33 years (Table 1); however, these differences were 
statistically insignificant. The increase in prevalence of cataract with 
increasing age has been investigated in several epidemiological studies. 
Kaluzny JJ et al., 199388 , in their study on 1075 men and 1247 women 
with senile cataract, reported a statistically significant difference between 
the mean ages of the men (63 years) and the women (65 years). Hodge W 
et al., 199536  describes increasing incidence of cataract with increasing 
age.In the Beaver Dam Study from 1988-9039,90 , Klein et al. noted cataract 
formation combined with visual acuity decrease to 20/30 or worse in 25% 
of females and 135 of males aged more than 75 years.  
 In the frequently-cited Framingham eye study91, of the 2675 
inhabitants investigated, lenticular opacification occurred in 80% of those 
aged more than 75 years; in 46%, vision was also decreased to 20/30 or 
worse. In a study on 5000 inhabitants in Sweden92, cataract prevalence was 
estimated to be 24% for women and 145 for males; inclusion of any 
previous cataract surgery raised prevalence to 42% in females and 27% in 
males.  
  Co-morbid systemic conditions noted in the patients in the two 
groups were hypertension, diabetes mellitus, hypercholesterolemia and 
coronary artery disease (Table 2). Overall, co-morbid conditions occurred 
in 60 (46%) of 130 patients in the SICS group and in 158 (40.5%) of 390 
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patients in the phacogroup (Table 2); this difference was statistically 
insignificant. Interestingly, co-morbid conditions occurred significantly 
more frequently in males (78 [48.4 %] of 161) than in females (140 [39%] 
of 359) studied (X2 [d.f.=1] = 4.47 ; P = 0.03) (Table 2). In the present 
study, hypertension was the most frequently associated co-morbid 
condition, affecting 57% of SICS individuals and 47% of phaco 
individuals. (Fig 2). Hypertension and diabetes mellitus were the most 
frequent co-morbid conditions in females in both groups, affecting 41% 
and 36%, respectively in the SICS group, and 43% and 35% in the phaco 
group (Table 2). Interestingly, hypertension was seen significantly more 
frequently in males (39 [24%] of 161 males) than in females (59 [16.4%] 
of 359 females) in the current study (X2 [d.f.=1] = 4.4 ; P=0.036).  
  Burgess et al.,93  in his study on 136 cataract patients, found 
systemic hypertension and diabetes mellitus to increase the risk of cataract 
occurrence. In the study by Behera et al.94  on 1627 individuals (49% males 
and 51% females), the prevalence of hypertension and diabetes mellitus 
was 20.59% and 5.95% respectively, with hypertension occurring more 
frequently in females (24.5% of 832 females) than in males (13.8% of 795 
males). However, the prevalence of diabetes that was reported, was nearly 
equal in both males and females i.e. 4.7% and 4.4% respectively. The 
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study concluded that cataract cases are usually associated with chronic 
systemic diseases like hypertension and diabetes. 
  In the current study, although diabetes mellitus occurred more 
frequently in females (49 [13.6%] of 359) than in males (17 [10.6%] of 
161), this difference was statistically insignificant. Cataracts more 
frequently in diabetics than in non-diabetics and at a younger age. 39,96   
 The most common type of cataract in diabetics including both the 
SICS and phaco groups was Posterior subcapsular cataract (43.9% [29 out 
of 66]). The Beaver Dam Eye study96  that reported similar results. 
Avraham et al.,97  confirmed the association of PSCC with diabetes ; these 
authors noted PSCC presence at multiple degrees of glucose bintolerance 
and hypothesized a possible independent role for non-enzymatic 
glycosylation. The occurrence of cataract in diabetics may impair the 
recognition of sight-threatening diabetic retinopathy at an early stage and 
there exists the risk of deterioration of retinopathy that may go 
unrecognized. Cataract surgery may also worsen diabetic maculopathy. 
Although, cataract surgery used to be deferred in diabetic patients until 
vision was severely disrupted, current day cataract surgical techniques can 
be done when the patient experiences symptoms and well before a serious 
impairment of the view of the retinal fundus.  
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 The present study used the LOCS classification to grade cataracts 
into nuclear cataracts NC1, NC2, NC3, NC4, NC5 and end stage cortical 
cataracts as mature or hypermature (MC/HMC) cataracts (Table 3). In the 
SICS group (total 130 patients) three patients (2%) had NC2, 52 (40%) had 
NC3, 38 (29%) had NC4, eight (6%) had NC5 and 29 (23%) had mature / 
hypermature cataracts; corresponding percentages in the phaco group (total 
390 patients) were 2%, 30%, 34%, 8% and 26%, respectively  
(Table 3). These differences were not statistically significant 
(χ2 [d.f.=4]=4.8; P=0.31).  
 In males NC2 cataracts were noted in 0.4 %, NC3 cataracts in 37%, 
NC4 cataracts in 26%, NC5 cataracts in 6.2% and mature / hypermature 
cataracts in 30.4%; in female patients, the percentages were 3%, 31%, 
35%, 9% and 22%, respectively. Interestingly, these gender differences 
approached statistical significance (χ2 [d.f.=4] = 10.6, P = 0.03 : with 
yates’ correction, χ2 = 8.63, P = 0.07) (Table 3). 
 According to Kleine et al.,39,90  there was an increasing incidence of 
nuclear cataract with increase in age. Women were more likely to have 
nuclear cataract than men, even after age adjustment. Women were more 
severely affected than men. The Blue mountain eye study83  done in 2003 
was a 5 year follow up study that examined 2335 patients; nuclear cataract 
followed by cortical cataract was found to be the most frequently occurring 
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type of lens opacity. Here also, women were found to have a significantly 
higher incidence of nuclear and cortical cataracts and cataract surgeries. 
Hormonal factors were cited to explain this higher difference.  
 In the present study, of the 520 patients who were enrolled, 390 
patients underwent manual SICS and 390 underwent cataract extraction by 
phacoemulsification. The 130 patients who underwent SICS had a post-
operative mean visual acuity (decimals) of 0.58 + 0.02, which was 
significantly higher than the pre-operative mean visual acuity of 0.07 + 
0.01 (unpaired `t’ [d.f.=258] = 21.6 ; P < 0.0001) (Table 4). This 
significant improvement was seen in both males and females in the SICS 
group (Table 4). Similarly, in the 390 patients who underwent 
phacoemulsification surgery, the post-operative mean visual acuity (0.64 + 
0.01) was significantly better than the pre-operative mean visual acuity of 
0.07 + 0.01 (unpaired `t’ [d.f.= 776) = 38.7 ; P < 0.0001) (Table 5). This 
significant improvement was seen in both males and females (Table 5). 
 Minassian et al.98  and Karki et al.,99  compared extra-capsular 
cataract extraction (ECCE) and SICS; they found that both were good for 
community cataract surgery, but that SICS gave a statistically better visual 
outcome. Phacoemulsification however remains the standard of care for 
cataract extraction in the western world. Advantages of 
phacoemulsification include the reduction in morbidity from cataract 
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surgery by reduction of the incision size, with subsequent faster recovery 
and decreased risk of complications including endophthalmitis. In addition, 
the learning curve for this procedure seems to be remarkably small.  
 Singh et al. (2009)46 sought to elucidate the outcomes of 
phacoemulsification versus SICS for cataract surgery in immature cataract. 
In this prospective randomized controlled trial performed on 
approximately 90 patients with immature senile cataract in each group 
taken for phacoemulsification or SICS, the groups did not differ 
significantly in terms of demographic details and in pre-operative vision. 
More than 66% of individuals in the phaco group and more than 75% of 
individuals in the SICS group had good visual acuity (6/6-6/18) the day 
after surgery, the difference again not being of statistical significance. 
Vision less than <6/60 was considered poor, and this was noted in 6% of 
individuals in the phaco group and in 1% of individuals in the SICS group. 
Average visual acuity in the phaco group was 0.43 ± 0.27, and in the SICS 
group was 0.47 ± 0.24. Interestingly, the average surgical time was 
statistically less in the SICS group as compared to the phacogroup. These 
authors concluded that SICS with the intraocular placement of 
polymethmethylacrylate lens is a relevant surgery for treatment of 
immature cataracts in Third World countries. 
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 Meeks et al. (2013)41 reported on a retrospective cohort evaluation 
of safety and effectiveness of phaco cataract extraction and extracapsular 
extraction performed by beginning resident surgeons in Texas, USA. Data 
were collected for cases performed over almost a 6-year period during 
which, initially the first primary surgeon cases does extracapsular cataract 
extraction and, later, the first primary surgeon cases performs 
phacoemulsification. Posterior chamber IOLs were placed in all but two 
phacoemulsification cases and in four patients in whom extracapsular 
cataract extraction was performed. These authors concluded that 
phacoemulsification cataract extraction can be taught safely and effectively 
to residents with no cataract surgery experience as a primary surgeon. 
 Rohit C Khanna et al.,100  compared the surgical outcomes of SICS 
and phacoemulsification performed by ophthalmology trainees. SICS 
group individuals were significantly older and with worse pre-operative 
visual acuity; however, BCVA ≥ 6/12 was achieved in more than 84% of 
individuals in both groups. 
 With reference to mean pre-operative visual acuities, differences 
between the groups were not significant. The differences in the pre-
operative mean visual acuity in the SICS group [0.08 + 0.01] and the 
Phaco group [0.06 + 0.01] in males with P=0.21 as well as the values of 
the SICS group [0.07 + 0.01] and the Phaco group [0.07 + 0.01] in females 
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were not statistically significant. Mean post-operative visual acuity 
between males in SICS and Phaco groups was not significant ; however, 
phaco group females had a significantly better mean post-operative visual 
acuity than SICS group females in the present study (Tables 3, 4).  
 Gogate et al. (2007)44 compared costs of SICS and phaco surgeries, 
in a hospital setting in India using standard norms. The participants 
included 400 patients and four surgeons and it reported that the cost of 
phacoemulsification cataract surgery was higher due to the cost of the 
foldable lens used. Moreover, phacoemulsification required additional 
expenditure to cover the financial depreciation of the instrument and the 
replacement of faulty or old parts. These authors concluded that SICS is 
cheaper, equally safe and yields a comparable visual outcome with that of 
phaco.  
 Ruit et al. (2007)45 aimed to evaluate the success and visual 
outcomes following phacoemulsification with that following SICS in 108 
individuals with significant cataracts. Both surgical techniques yielded 
comparable surgical outcomes with few complications. The day after 
surgery, both groups had almost similar levels of uncorrected visual acuity 
(UCVA) while a lower degree of corneal oedema occurred in the SICS 
group. In the six-month follow-up period, almost 90% of the individuals 
who had undergone SICS exhibited UCVA 20/60 or more, while 98% 
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exhibited best-corrected visual acuity of 20/60 or more versus 85% of the 
individuals in the phacoemulsification group with UCVA of 20/60 or more 
and 98% with BCVA of 20/60 or more; the difference did not yield 
statistical significance. Interestingly, SICS took a shorter time to perform 
than did phacoemulsification. These authors concluded that both surgical 
techniques resulted in good visual recoveries with fewer complications. 
However, they also opined that since SICS can be performed in a shorter 
time duration, is less costly and independent of high-end technology unlike 
phacoemulsification, SICS might be a more relevant option to use to treat 
advanced cataracts in the developing countries.  
 The prevalence of cataract surgery as well as factors in association 
with post-surgical outcomes of vision in migrant Indians living in 
Singapore was studied by Gupta et al. (2013)48, A population-based study 
was conducted on 3, 400 Indian immigrants residing in Singapore. The 
age- and gender-standardized prevalence of cataract surgery was 9.7% in 
Singapore resident Indians, while the post-operative visual impairment, as 
defined by best corrected visual acuity, was found to occur in 10.9% of the 
eyes studied. These authors concluded that socioeconomic variables and 
migration did not significantly contribute to the prevalence of cataract 
surgery, and that diabetic retinopathy was a major cause of postoperative 
visual impairment in migrant Indians living in Singapore.  
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 Biochemical analysis of the cataractous lenses was done using SDS-
PAGE, with the gel being imaged and analyzed with QuantityOne 
software. The normal lens nuclei constituted Lane N, with most proteins 
having molecular weight of 12 to 30 kDa. The band intensities of the 
cataractous lens samples, showed a statistically significant reduction in 
intensity, which was evident visibly, when compared with the band 
intensity of normal lens nuclei. With increasing nuclear sclerosis, the 
staining intensity of bands corresponding to 29 and 20 kDa proteins was 
found to notably decrease. In mature/hypermature cataractous lens 
samples, many proteins were found to be missing in the gel, when 
compared to the pattern in normal lenses. In contrast, the distribution of 
proteins in NC2 cataractous lens samples was similar to that obtained in 
samples from normal lenses. The results of the present study conform to 
the findings by Abbott et al.,21 who describes two-dimensional 
electrophoresis (2-DE) and mass spectrometric analysis (MS) as important 
tools in the promising field of proteomics; these are greatly useful in 
determining the modifications in lenticular crystalline proteins that 
contribute to cataractogenesis. 2-DE is capable of simultaneously resolving 
complex mixtures of modified crystallins. These resolved crystallins can 
be then quantified by image analysis These perceived differences in band 
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staining intensity, as assessed by the naked eye, may be subjected to 
intensity analysis of the SDS-PAGE images using computer software.  
 To further confirm the protein degradation observed on SDS-PAGE, 
two dimensional gel electrophoresis (2-DE) was performed in the present 
study and the gel spots corresponding to α-crystallin from the different 
grades of cataractous lenses were selected. These spots were then subjected 
to MALDI-TOF analysis in order to ascertain the crystallin identification. 
Varying concentrations of alpha-crystallin was identified in all the lens 
samples. 
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SUMMARY 
 The present dissertation studied the clinical and biochemical aspects 
of senile cataracts in patients presenting with diminished vision due to 
lenticular opacification at the Institute of Ophthalmology, Joseph Eye 
Hospital, Tiruchirapalli, Tamilnadu, over a period of 11 months 
(December 1, 2011 to October 31, 2012. Of the 604 patients enrolled, 
analysis could be performed for the clinical aspects of the study only on 
520 patients. 
Patients who were enrolled in the study underwent monoocular 
cataract surgery either by small incision cataract surgery (SICS) (130 
patients) or by phacoemulsification (390 patients). Patients in the SICS 
group and phaco group were, essentially, age-and gender-matched. 
Hypertension was, by far, the most frequent co-morbid condition in males 
in both SICS and phaco groups, affecting 57% in the SICS group and 47% 
in the phaco group. Hypertension was also more common in males and 
although diabetes mellitus occurred more frequently in females, this 
difference was not statistically significant. Various grades of nuclear 
cataract (NC), posterior subcapsular cataract (PSCC) and end-stage cortical 
cataracts namely mature (MC) and hypermature (HMC) were seen in the 
patients. These cataracts were graded according to the LOCS classification 
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III.NC3 (40%) and NC4 (34%) were the most common types of cataracts 
in the SICS and phaco group respectively.NC 3 (37%) and NC4 (35%) 
were the most common subtypes among males and females. Interestingly, 
these gender differences approached statistical significance. PSCC 
cataracts were noted (in association with nuclear cataracts) in 71 males and 
179 females. PSCC 1 cataract was the most common grade of PSC 
(46.5%) and in females (49.7%).  
The mean pre-operative visual acuities showed no significant 
differences between the SICS and phaco groups.The post-operative mean 
visual acuity (decimals) in the SICS and phaco groups was 0.58 + 0.02 and 
0.64 + 0.01, respectively and it was significantly better than the pre-
operative mean visual acuity in both the SICS and phaco groups (0.07 + 
0.01 and 0.07 + 0.01 ) respectively. This significant improvement was seen 
in both males and females. Though there was no post-operative mean 
visual acuity difference between SICS and phaco in males, such a 
difference existed in females with better visual acuity in the phaco group. 
When all patients were considered, the post-operative mean visual acuity 
in the Phaco group was higher than that in the SICS group, and this 
difference approached statistical significance with P = 0.06. 
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 The frequency of surgical and post-operative complications, pre-
existing pathology and combined surgery was compared between the SICS 
and Phaco groups. Combined surgery was needed for 13 (10.0 %) of 130 
SICS group patients and 17 (4.4 %) of 390 phaco group patients, this 
difference was statistically significant (P=0.03).  
  Different degrees of post-operative (PO) visual acuity (Snellen’s 
units) in relation to pre-operative cataract grade were compared in patients 
who had undergone SICS and in those who had undergone 
phacoemulsification cataract surgery. Interestingly, significant differences 
between the SICS and Phaco groups were observed, when PO visual 
acuities were assessed against pre-operative mature and hypermature 
cataract grades. In the Phaco group, of 100 individuals who exhibited 
preoperative mature or hypermature cataracts, 69 (69%) achieved PO 
visual acuities of 6/6 or 6/9 while 31 (31%) achieved PO visual acuities of 
6/12, 6/18 or 6/24. This difference was statistically significant ( P=0.02).  
 The biochemical analysis was done after SDS-PAGE, and the gel 
was imaged and analyzed with Quantity One software. In the normal lens 
nuclei (Lane N), most proteins were 12 to 30 kDa (Fig 14). In the 
cataractous lens samples (Lanes S1, S2, S3, S4 and S5), the band 
intensities at ∼20 kDa visibly (P < 0.05) showed a gradual reduction in 
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intensity, when compared with the band intensity of normal lens nuclei. 
With increasing nuclear sclerosis, the staining intensity of bands 
corresponding to 29 and 20 kDa proteins was found to notably decrease 
(Fig 14). In mature/hypermature cataractous lens samples, many proteins 
were absent in the gel, when compared to the pattern in normal lenses. In 
contrast, the distribution of proteins in NC2 cataractous lens samples (lane 
S1) was similar to that obtained in samples from normal lenses (lane N). 
These perceived differences in band staining intensity, as assessed by the 
naked eye, were reinforced by intensity analysis of the SDS-PAGE images 
using computer software. To further confirm the protein degradation 
observed on SDS-PAGE, two dimensional gel electrophoresis (2-DE) was 
performed and the gel spots corresponding to α-crystallin from the 
different grades of cataractous lenses were selected (Fig. 15). These spots 
were then subjected to MALDI-TOF analysis in order to ascertain the 
crystallin identification. Alpha-crystallin was identified in all the lens 
samples, although the concentration varied. 
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CONCLUSION 
 The results of the present study suggest that both SICS and 
phacoemulsification yield satisfactorily similar visual outcomes. Females 
undergoing phacoemulsification may achieve better visual outcomes than 
males. Aside from this, there are no other obvious factors (grade of 
cataract, associated ocular and systemic comorbid conditions, combined 
surgery) that would favour choosing one procedure rather than the other. 
Other considerations such as cost, may influence the final decision. But a 
study of these influences was outside the scope of the present study. 
Additional studies are needed on a larger cohort of patients over a longer 
time duration to identify possible factors that may favour one procedure 
over the other. Additional biochemical studies on various grades of human 
cataract may help in identifying factors triggering cataractogenesis; an 
understanding of these biochemical factors may pave the way for medical 
management of cataract. 
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Proforma 
PROFORMA   
IP no: 
Age: 
Sex: 
Occupation : 
Socioeconomic status: 
Heredity: 
Personal history: 
h/o dehydrational crisis or malnutrition 
h/o alchohol 
h/o smoking 
Visual complaints: 
• decreased v/a: 
• glare: 
• myopic shift 
  
Clinical assessment 
Systemic associations: 
hypertension 
diabetes mellitus 
hypercholesterolemia 
coronary artery disease 
allergy 
  
Ocular associations: 
Glaucoma 
High myopia 
Eye to be operated: 
Pre-operative vision: 
Type of cataract: 
Stage : 
Surgical procedure: 
Intra- or post-operative complications 
Post-operative vision: 
 
 
Vision in the other eye: 
Cataract type if any in the other eye: 
 
Master Chart 
IP NO age sex
decreased 
v/a
HTN DM
hyperchol
estremia
CAD EYE OP preop vn
pre-op 
decimal
type of 
cataract
postop Vn post dec
1053001 62 M 6//6 3//60 LE 3//60 0.05 NS3 PSCC3 6//6 1
1052974 56 M 1//60 1//60 LE 1//60 0.02 NS2 PSCC2 6//6 1
1053000 57 M 5//60 6//12 RE 5//60 0.08 NS2 6//6 1
1052976 62 M 3//60 2//60 P P LE 2//60 0.04 NS2 PSCC2 6//12 0.5
1052098 56 M 6//6 6//24 P P LE 6//24 0.25 NS2 PSCC1 6//6 1
1053191 59 M 6//24 6//24 RE 6//24 0.25 NS2 6//9 0.63
1053544 60 M 6//60 PL+ LE PL+ 0 MC 6//6 1
1053525 60 M 6//18 6//6 RE 6//18 0.33 NS2 6//6 1
1053547 63 M 4//60 6//12 P RE 4//60 0.07 NS3 PSCC1 6//6 1
1053558 62 M 6//60 6//18 RE 4//60 0.07 NS3 6//6 1
1053543 62 M 2//60 1//60 LE 1//60 0.02 MC 6//24 0.25 pcr+sfiol
1054270 54 M 1//60 6//9 RE 1//60 0.02 NS2 PSCC3 6//9 0.63
1054091 56 M 5//60 6//60 P P LE 5//60 0.08 NS2 PSCC2 6//6 1
1054085 59 M 6//12 1//60 LE 1//60 0.02 NS2 PSCC2 6//6 1
1044739 60 M 6//18 PL+ P P LE PL+ 0 MC 6//12 0.5 sk
1027277 64 M 6//12 5//60 LE 5//60 0.08 NS2 PSCC1 6//12 0.5
1054656 70 M 6//60 NO PL RE 6//60 0.01 NS2 PSCC1 6//6 1
1054729 59 M 6//12 6//18 LE 6//18 0.33 NS2 PSCC2 6//6 1
1054705 57 M 6//18 6//36 LE 6//36 0.17 NS3 6//12 0.5
1054000 54 M 6//18 2//60 P LE 2//60 0.04 NS4 6//60 0.1 ARMD
1054704 71 M 6//60 6//12 RE 6//60 0.1 PSCC2 6//12 0.5
1055353 58 M 5//60 5//60 P P P RE 5//60 0.08 NS2 6//12 0.5
1055354 59 M 6//12 6//60 LE 6//60 0.1 NS2 PSCC1 6//18 0.33
1054703 69 M 6//36 PL+ P LE PL+ 0 MC 5//60 0.8
1055202 65 M 4//60 2//60 LE 2//60 0.04 NS3 PSCC1 6//18 0.33
1055355 58 M 6//12 PL+ P LE PL+ 0 MC 6//24 0.25
1055466 64 M 2//60 5//60 RE 2//60 0.04 MC 6//18 0.33
1055425 62 M 6//12 CFC P LE PL+ 0 MC 6//12 0.5
1055499 62 M 6//36 6//60 P LE 6//60 0.1 NS2 6//12 0.5
1055500 66 M 6//24 6//12 RE 6//24 0.25 NS2 6//6 1
1055511 60 M PL+ 6//36 RE PL+ 0 MC 6//9 0.63
1055501 67 M PL+ 6//36 RE PL+ 0 NS3 6//9 0.63
1005794 52 M 6//24 6//18 RE 6//24 0.25 NS2 6//9 0.63
1055788 59 M 5//60 6//18 RE 5//60 0.08 NS3 PSCC 6//9 0.63
1055663 64 M 2//60 1//60 LE 1//60 0.02 NS3 6//6 1
1056307 61 M 6//12 5//60 LE 5//60 0.08 NS3 6//18 0.33 dense SK
1056423 64 M 6//12 2//60 LE 2//60 0.04 NS3 6//12 0.5 combined
1043828 67 M 6//24 PL+ P LE PL+ 0 MC 6//9 0.63
1056424 57 M 1//60 5//60 P P RE 1//60 0.02 HMC 6//9 0.63 pxf
1052980 48 F 1//60 05//60 P P LE 1//60 0.02 MC 6//6 1
MASTER CHART - SICS GROUP
1052979 60 F 6//18 1//60 LE 1//60 0.02 NS3 PSCC1 6//6 1
1052981 58 F 1//60 0.5//60 P LE 1//60 0.02 NS4 6//6 1
1052978 70 F 5//60 2//60 LE 2//60 0.04 NS2 PSCC3 6//9 0.63
1052977 67 F 1//60 4//60 P P P RE 1//60 0.02 NS3 PSCC2 6//9 0.63
1053151 68 F PL+ 6//6 RE PL+ 0 MC 6//18 0.33 dense sk
1038982 59 F 6//36 4//60 LE 4//60 0.07 NS2 PSCC2 6//9 0.63
1053179 70 F 6//36 1//60 LE 1//60 0.02 NS3 PSCC 6//9 0.63
1053178 66 F 6//36 4//60 LE 4//60 0.07 NS3 PSCC 6//6 1
1053180 63 F 6//36 3//60 P LE 3//60 0.05 NS2 PSCC2 6//9 0.63 combined
1053141 61 F 6//12 1//60 LE 1//60 0.02 NS4 6//9 0.63
1053167 65 F 5//60 6//60 RE 5//60 0.08 NS2 PSCC2 6//9 0.63
1053177 52 F 6//18 PL+ P LE PL+ 0 MC 6//9 0.63
1053190 58 F 6//36 6//24 RE 6//36 0.17 NS3 PSCC1 6//6 1
1053050 56 F PL+ PL+ RE PL+ 0 HMC 6//9 0.63
1011070 60 F 5//60 6//9 RE 5//60 0.08 NS2 PSCC2 6//9 0.63
1033501 61 F 6//9 6//24 LE 6//24 0.25 NS3 6//6 1
1039633 66 F 6//12 PL+ LE PL+ 0 HMC 6//9 0.63
1053314 67 F PL+ 1//60 RE PL+ 0 MC 6//9 0.63
1053555 72 F 6//24 5//60 LE 5//60 0.08 NS4 6//18 0.33 combined
1053556 69 F 3//60 6//12 RE 3//60 0.05 NS4 PSCC2 6//9 0.63
1053492 65 F HM 6//6 RE 1//60 0.02 MC 6//6 1
1053537 54 F 6//36 3//60 P P LE 3//60 0.05 NS3 PSCC3 6//9 0.63
1053538 57 F CFC 3//60 RE PL+ 0 MC 6//9 0.63
1053548 58 F 3//60 6//24 RE 3//60 0.05 NS3 PSCC2 6//18 0.33
1053552 59 F 4//60 6//24 RE 4//60 0.07 NS2 PSCC3 6//9 0.63
1052653 59 F PL+ PL+ P P LE 6//60 0.1 MC 6//12 0.5
1053557 61 F 6//9 HM LE PL+ 0 NS3 PSCC 6//9 0.63 combined
1046112 63 F 3//60 1//60 P LE 1//60 0.02 NS2 PSCC2 6//6 1
1053553 63 F HM 5//60 RE PL+ 0 HMC 5//60 0.08 dense sk
1054154 61 F 2//60 PL+ LE PL+ 0 MC 6//60 0.1 brvo
1054232 60 F 5//60 6//24 P RE 5//60 0.08 NS2 6//9 0.63
1054174 67 F 6//18 6//12 RE 6//18 0.33 NS2 PSCC1 6//9 0.63
1054230 66 F 6//18 6//24 LE 6//24 0.25 NS2 PSCC1 6//9 0.63
1054231 70 F 3//60 6//12 P RE 3//60 0.05 NS2 PSCC1 6//9 0.63
1054229 49 F 2//60 2//60 P RE 2//60 0.04 NS3 6//12 0.5
1054234 65 F 5//60 5//60 LE 5//60 0.08 NS1 PSCC3 6//9 0.63
1054152 61 F 6//60 6//9 RE 6//60 0.1 NS2 PSCC1 6//9 0.63
1054233 60 F 6//18 6//12 RE 6//18 0.33 NS2 6//9 0.63
1054359 65 F 6//36 3//60 LE 3//60 0.05 NS3 PSCC2 6//9 0.63
1052128 62 F 6//18 6//12 RE 6//18 0.33 NS2 6//9 0.63
1054113 60 F 5//60 6//12 P P RE 5//60 0.08 NS2 PSCC2 6//9 0.63
1054543 66 F 6//60 3//60 LE 3//60 0.05 NS3 PSCC 6//24 0.25 combined
1054538 61 F 5//60 HM LE 1//60 0.02 NS3 PSCC1 6//9 0.63
1054536 56 F 6//36 PL+ LE PL+ 0 MC 6//12 0.5
1054342 59 F 2//60 NO PL RE 2//60 0.04 NS2 PSCC1 6//6 1
1054532 67 F 6//12 6//60 LE 6//60 0.1 NS1 PSCC2 6//12 0.5
1054417 65 F HM 6//12 P P RE 1//60 0.02 MC 6//9 0.63
1054659 68 F CFC 6//18 RE PL+ 0 NS3 PSCC2 6//36 0.17
1055143 59 F 6//24 6//36 P P LE 6//36 0.17 NS2 6//18 0.33
1054744 73 F 6//18 6//24 LE 6//24 0.25 NS2 PSCC1 6//6 1
1055235 69 F HM PL+ LE PL+ 0 MC 6//12 0.5
1055230 69 F 6//12 5//60 LE 5//60 0.08 NS2 PSCC1 6//24 0.25 dense sk
1055232 59 F 6//36 6//12 RE 6//36 0.17 NS2 PSCC2 6//9 0.63
1055288 58 F 6//9 6//18 LE 6//18 0.33 NS1 PSCC2 6//9 0.63
1055242 60 F 6//18 6//36 LE 6//36 0.17 NS2 6//12 0.5
1055204 60 F 6//60 6//36 P P RE 6//60 0.1 NS2 PSCC2 6//36 0.17 brvo
1036572 62 F 6//18 3//60 P LE 3//60 0.05 NS3 6//9 0.63
1055356 59 F 3//60 6//60 RE 3//60 0.05 NS3 6//18 0.33
1055357 64 F 6//60 3//60 LE 3//60 0.05 NS2 6//36 0.17
1055359 63 F 6//60  6//60 LE 6//60 0.1 NS3 6//12 0.25
1055360 58 F 5//60 6//18 RE 5//60 0.08 NS2 6//9 0.33
1055358 58 F 3//60 6//12 P RE 3//60 0.05 NS4 6//12 0.5
1055223 63 F 6//18 PL+ LE PL+ 0 MC 6//24 0.25
1055274 57 F PL+ 6//24 RE PL+ 0 NS4 1//60 0.02
1055361 74 F 5//60 5//60 RE 5//60 0.08 NS2 PSCC 6//9 0.63
1055506 61 F 6//24 1//60 P LE 1//60 0.02 TC 6//12 0.25
1055498 65 F 1//60 2//60 P RE 1//60 0.02 NS3 6//12 0.25
1055513 62 F 6//36 1//60 LE 1//60 0.02 NS2 6//18 0.33
1055512 60 F 6//24 3//60 LE 3//60 0.05 NS3 6//9 0.63
1055502 63 F PL+ 0.5//60 RE PL+ 0 MC 6//12 0.5
1055641 59 F 5//60 6//24 RE 5//60 0.08 NS2 PSCC 6//24 0.25
1055659 57 F 0.5//60 1//60 RE 1//60 0.02 NS2 6//24 0.25
1055572 59 F 6//60 6//9 RE 6//60 0.1 NS3 6//12 0.5 drusen
1055362 58 F 5//60 5//60 P RE 5//60 0.08 NS2 3//60 0.05
1055793 69 F 5//60 PL+ LE PL+ 0 MC 6//6 1
1055792 64 F 6//12 CFC LE PL+ 0 NS4 PSCC1 6//9 0.63
1055844 59 F 6//12 5//60 P LE 5//60 0.08 NS3 6//9 0.63
1055795 60 F 6//24 1//60 P P LE 1//60 0.02 NS3 PSCC 5//60 0.08 VMT
1055790 62 F 6//60 PL+ LE PL+ 0 NS3 6//18 0.33
1055789 67 F 5//60 5//60 RE 5//60 0.08 NS2 6//6 1
1056421 63 F 1//60 6//36 P P P RE 1//60 0.02 NS3 6//12 0.5
1056313 66 F 6//36 1//60 LE 1//60 0.02 NS2 6//12 0.5
1056347 59 F 6//36 2//60 LE 2//60 0.04 NS2 6//9 0.63
1056309 58 F 6//36 5//60 LE 5//60 0.08 NS2 6//18 0.33 COMBINED
1056349 59 F 6//36 2//60 LE 2//60 0.04 NS3 PSCC 6//9 0.63
1056317 60 F 5//60 3//60 P P P LE 3//60 0.05 NS3 PSCC 6//9 0.63
1056411 62 F 6//18 6//60 LE 6//60 0.1 NS2 6//12 0.5
1056413 60 F PL+ 1//60 RE 3//60 0.05 MC 6//12 0.5
1056362 62 F 3//60 6//24 RE 3//60 0.05 NS3 6//12 0.5 combined
1056420 57 F 3//60 6//60 P RE 3//60 0.05 NS3 6//9 0.63
MR.NO. AGE SEX RE LE HTN DM CHOL CAD
EYE 
Operated
pre-op snellen grade grade
post-op 
V/A
snellen complic
1001422 60 M 2//60 1//60 LE 0.02 1//60 NS3 PSCC3 1 6//6
1001538 56 M 3//60 6//12 RE 0.05 3//60 NS2 PSCC2 1 6//6
1001547 57 M 2//60 2//60 RE 0.04 2//60 NS2 1 6//6
1001588 62 M 5//60 5//60 P p LE 0.08 5//60 NS2 PSCC2 0.5 6//12
1001755 56 M 6//12 5//60 P P P LE 0.08 5//60 NS2 PSCC1 1 6//6
1001925 59 M 6//60 3//60 LE 0.05 3//60 NS2 0.63 6//9
1002106 61 M 6//24 6//36 LE 0.17 6//36 NS3 1 6//6
1002112 64 M 5//60 6//60 RE 0.08 5//60 NS2 PSCC2 1 6//6
1002113 63 M 6//60 1//60 LE 0.02 1//60 NS3 PSCC1 1 6//6
1002114 62 M HM PL+ LE 0 PL+ HMC 1 6//6
1002115 62 M 6//60 6//36 RE 0.1 6//60 NS4 0.25 6//24 PCR+SFIOL
1002116 52 M 6//36 PL+ LE 0 PL+ MC 0.63 6//9
1002118 56 M 6//18 PL+ P P p LE 0 PL+ MC 1 6//6
1002119 65 M 4//60 2//60 LE 0.04 2//60 NS3 PSCC2 1 6//6
1020699 59 M 6//12 PL+ P LE 0 PL+ MC 0.5 6//12 pxf
1020757 64 M 2//60 5//60 RE 0.04 2//60 NS3 PSCC2 0.5 6//12
1020770 70 M PL+ 0.5//60 RE 0 PL+ MC 1 6//6
1020784 59 M 5//60 6//24 RE 0.08 5//60 NS2 PSCC2 1 6//6
1020872 57 M 0.5//60 1//60 RE 0.02 1//60 NS3 PSCC2 0.5 6//12
1020881 54 M 6//60 6//9 P P RE 0.1 6//60 NS4 0.1 6//60 SFIOL
1020901 67 M 5//60 5//60 RE 0.08 5//60 NS3 PSCC1 0.5 6//12
1020929 62 M 6//12 5//60 P P p LE 0.08 5//60 NS2 PSCC1 0.5 6//12
1020936 65 M 6//24 6//60 LE 0.1 6//60 NS3 PSCC1 0.33 6//18 combined
1020981 58 M 6//36 2//60 P P LE 0.04 2//60 NS2 PSCC3 0.5 6//12
1021143 59 M 6//36 5//60 LE 0.08 5//60 NS2 PSCC1 0.33 6//18 Drusen at fovea
1021163 69 M 6//24 PL+ P LE 0 PL+ MC 0.08 5//60
1021164 65 M PL+ 1//60 RE 0 PL+ HMC 0.33 6//18
1021185 58 M 3//60 6//60 P RE 0.05 3//60 MC 0.25 6//24 combined
1021203 64 M 6//6 3//60 LE 0.05 3//60 MC 0.33 6//18
1021205 62 M 6//18 1//60 P LE 0.02 1//60 MC 0.5 6//12
1021231 62 M 1//60 0.5//60 LE 0.02 0.5//60 NS4 PSCC1 0.5 6//12
1021243 66 M 5//60 2//60 LE 0.04 2//60 NS3 PSCC1 1 6//6
1021258 60 M 1//60 4//60 RE 0.02 1//60 MC 0.63 6//9
1021259 64 M 6//12 1//60 LE 0.02 1//60 MC 0.63 6//9
1021260 52 M 6//24 6//24 RE 0.25 6//24 NS2 0.63 6//9
1021263 59 M PL+ PL+ RE 0 PL+ HMC 0.63 6//9
1021265 64 M 6//12 PL+ LE 0 PL+ HMC 0.04 2//60 dense SK
1021266 61 M HM 6//6 RE 0.02 HM NS4 1 6//6
1021267 64 M 6//18 6//6 RE 0.33 6//18 NS3 1 6//6
1021268 67 M 4//60 6//12 P P RE 0.07 4//60 MC 0.63 6//9
1021274 57 M 6//60 6//18 P P RE 0.1 6//60 NS2 PSCC1 0.63 6//9
1021275 58 M 2//60 PL+ LE 0 PL+ HMC 1 6//6
1021276 62 M 2//60 2//60 RE 0.04 2//60 NS3 PSCC1 1 6//6
1021277 59 M 5//60 5//60 P LE 0.08 5//60 NS2 PSCC2 1 6//6
1021278 61 M 6//60 6//9 RE 0.1 6//60 NS4 0.63 6//9 PC RENT
1021279 70 M 6//18 PL+ P p LE 0 PL+ MC 1 6//6
1021315 61 M 5//60 HM LE 0.02 HM HMC 0.63 6//9
MASTER CHART - PHACO GROUP
1021319 56 M 4//60 6//24 RE 0.07 4//60 NS2 PSCC3 1 6//6
1021363 67 M 6//60 1//60 LE 0.05 1//60 NS3 PSCC1 0.63 6//9
1021368 65 M HM PL+ LE 0 PL+ HMC 0.33 6//18
1021373 70 M 6//12 5//60 P P p LE 0.08 5//60 NS3 PSCC2 1 6//6
1021390 71 M 6//18 3//60 LE 0.05 3//60 MC 0.5 6//12 BRVO
1021400 60 M 6//18 PL+ P LE 0 PL+ MC 0.63 6//9
1021401 60 M 4//60 2//60 LE 0.04 2//60 NS3 PSCC2 0.5 6//12
1021402 62 M PL+ 6//24 RE 0 PL+ HMC 0.63 6//9
1021404 58 M 5//60 5//60 LE 0.08 5//60 NS3 PSCC2 0.63 6//9
1021405 74 M 5//60 6//24 RE 0.08 5//60 NS2 PSCC2 0.5 6//12
1021406 64 M 0.5//60 1//60 LE 0.02 0.5//60 NS3 PSCC1 1 6//6
1021416 62 M 6//60 6//9 P RE 0.1 6//60 NS4 0.5 6//12 SFIOL
62 M PL+ 6//36 RE 0 PL+ MC 0.63 6//9
1022065 60 M 5//60 PL+ P P LE 0 PL+ MC 1 6//6
1022150 62 M 6//60 3//60 LE 0.05 3//60 NS3 PSCC2 0.17 6//36
1022171 60 M 5//60 HM LE 0.02 HM MC 0.5 6//12
1022349 59 M CFC 6//18 RE 0.02 CFC MC 0.5 6//12
1022367 52 M 6//60 6//12 RE 0.1 6//60 NS3 PSCC1 0.17 6//36
1022465 67 M HM PL+ LE 0 PL+ MC 0.17 6//36 BRVO
1022478 66 M 6//36 6//12 RE 0.33 6//36 NS3 0.63 6//9
1022492 59 M 6//18 6//36 LE 0.33 6//36 NS1 PSCC1 0.08 5//60
1022506 59 M 6//18 3//60 P LE 0.05 3//60 NS2 PSCC3 0.33 6//18
1022507 60 M 3//60 6//60 RE 0.05 3//60 NS2 PSCC2 0.1 6//60
1022509 62 M 5//60 5//60 RE 0.08 5//60 NS2 PSCC1 0.25 6//24
1022515 64 M 6//12 6//60 LE 0.1 6//60 NS3 PSCC1 0.63 6//9
1022517 67 M 6//60 3//60 P p RE 0.1 6//60 NS2 PSCC1 0.33 6//18
1022565 67 M 5//60 5//60 P RE 0.08 5//60 NS2 PSCC1 0.5 6//12
1022577 59 M PL+ 6//36 RE 0 PL+ MC 0.17 6//36
1022578 70 M 6//24 1//60 P P LE 0.02 1//60 NS3 PSCC2 1 6//6
1022691 61 M 6//24 3//60 LE 0.05 3//60 NS2 PSCC2 0.63 6//9
1022710 58 M 6//60 6//9 RE 0.1 6//60 NS2 PSCC2 0.04 2//60
1022749 67 M 4//60 6//18 P p RE 0.07 4//60 NS4 0.33 6//18 ARMD
1022754 72 M 5//60 6//18 P P p RE 0.08 5//60 NS3 PSCC1 0.63 6//9
1022755 69 M 6//24 1//60 LE 0.02 1//60 MC 0.63 6//9
1022844 60 M 6//36 1//60 LE 0.02 1//60 NS3 PSCC1 1 6//6
1022905 59 M 5//60 3//60 LE 0.05 3//60 NS2 PSCC3 1 6//6
1022917 61 M 6//18 6//60 P LE 0.1 6//60 NS2 PSCC2 1 6//6
1022926 63 M 6//12 2//60 LE 0.04 2//60 MC 0.63 6//9 PC RENT
1023075 49 M 6//60 PL+ P LE 0 PL+ MC 0.63 6//9
1023223 54 M 4//60 6//12 RE 0.07 4//60 MC 0.63 6//9
1023716 59 M 2//60 2//60 RE 0.07 4//60 NS2 PSCC1 0.5 6//12
1023774 65 M 6//60 6//9 RE 0.1 6//60 NS3 PSCC1 1 6//6
1023806 70 M 1//60 6//9 RE 0.02 1//60 NS3 PSCC3 0.5 6//12
1023818 59 M 5//60 6//60 P P RE 0.08 5//60 MC 0.33 6//18
1025283 59 M 6//12 5//60 LE 0.08 5//60 MC 0.5 6//12 BRVO
1025396 60 M 6//60 NO PL P RE 0.1 6//60 NS2 PSCC2 0.5 6//12
1025447 62 M 6//12 6//18 LE 0.33 6//18 NS2 PSCC2 0.08 5//60
1025449 59 M 6//18 6//36 RE 0.17 6//36 NS2 0.25 6//24
1025521 59 M CFC 6//18 RE 0.02 CFC NS3 PSCC2 0.1 6//60
1025524 63 M 6//24 6//36 LE 0.17 6//36 NS2 0.63 6//9
1025763 59 M 6//60 6//36 LE 0.1 6//60 NS2 PSCC2 0.63 6//9
1025764 57 M 6//18 3//60 LE 0.05 3//60 NS3 0.5 6//12
1025766 54 M 3//60 6//60 P RE 0.05 3//60 NS4 0.25 6//24 SFIOL
1025774 68 M 5//60 5//60 RE 0.08 5//60 NS3 PSCC2 0.25 6//24
1025932 59 M 6//60 3//60 P P LE 0.05 3//60 NS2 0.63 6//9
1025986 65 M 3//60 6//12 LE 0.05 3//60 NS3 PSCC2 0.63 6//9
1026012 69 M 6//36 PL+ LE 0 PL+ MC 0.63 6//9
1026135 59 M 6//24 6//12 RE 0.05 6//24 NS2 PSCC1 1 6//6
1026137 64 M PL+ 6//36 RE 0 PL+ NS2 0.63 6//9
1026145 63 M PL+ 0.5//60 RE 0 PL+ MC 1 6//6
1026152 57 M 0.5//60 1//60 RE 0.02 1//60 NS4 0.63 6//9
1026226 74 M PL+ 6//36 RE 0 PL+ NS2 PSCC 1 6//6
1026235 62 M 5//60 PL+ P LE 0 PL+ MC 1 6//6
1026250 62 M 6//12 CFC LE 0.02 CFC NS2 1 6//6
1026271 66 M 6//12 5//60 LE 0.08 5//60 NS2 1 6//6
1026274 60 M 6//24 6//18 RE 0.25 6//24 MC 1 6//6
1026276 61 M 5//60 6//18 P RE 0.08 5//60 TC 0.63 6//9
1026139 58 M 6//36 5//60 P LE 0.08 5//60 NS2 0.5 6//12 combined
1026276 61 M 5//60 6//9 RE 0.08 5//60 NS3 0.63 6//9
1026279 59 M 6//9 6//24 LE 0.25 6//24 NS2 0.63 6//9
1026285 58 M 6//12 PL+ LE 0 PL+ NS2 1 6//6
1026287 59 M PL+ 1//60 RE 0 PL+ NS3 PSCC 0.63 6//9
1026288 60 M 6//24 5//60 P P p LE 0.08 5//60 NS3 PSCC 0.63 6//9
1026135 59 M 6//24 6//12 RE 0.05 6//24 NS2 PSCC1 1 6//6
1026137 64 M PL+ 6//36 RE 0 PL+ NS2 0.63 6//9
1001418 59 F 3//60 5//60 P RE 0.05 3//60 NS4 PSCC1 1 6//6
1001424 60 F 2//60 PL+ LE 0 PL+ NS3 PSCC1 1 6//6
1001435 58 F 5//60 6//24 P RE 0.08 5//60 NS4 1 6//6
1001470 72 F 6//18 6//12 RE 0.1 6//60 NS2 PSCC3 0.63 6//9
1001528 66 F 6//18 6//24 P P P LE 0.25 6//24 NS3 PSCC2 0.63 6//9
1001664 63 F 6//60 6//9 RE 0.1 6//60 NS3 PSCC 0.33 6//18 PC RENT PXF
1001664 59 F 1//60 6//9 RE 0.02 1//60 NS2 PSCC2 0.63 6//9
1001679 70 F 5//60 6//60 RE 0.08 5//60 NS3 PSCC 0.63 6//9
1001704 66 F 6//12 1//60 LE 0.02 1//60 NS3 PSCC 1 6//6
1001718 63 F 6//18 6//60 P LE 0.1 6//60 NS2 PSCC2 0.63 6//9
1001719 61 F 6//18 PL+ LE 0 PL+ NS4 0.63 6//9
1001728 65 F 6//36 3//60 LE 0.05 3//60 NS2 PSCC2 0.63 6//9
1001784 52 F 6//18 PL+ P P P LE 0 PL+ MC 0.63 6//9
1001924 58 F 5//60 6//12 RE 0.08 5//60 NS3 PSCC1 1 6//6
1001944 56 F 5//60 HM LE 0.02 HM MC 0.63 6//9
1001957 60 F 6//36 PL+ LE 0 PL+ NS3 PSCC2 0.63 6//9
1001967 61 F 2//60 NO PL RE 0.04 2//60 NS3 PSCC1 1 6//6 POAG Combined
1001969 66 F 6//12 6//60 LE 0.1 6//60 NS3 0.63 6//9
1001973 67 F HM 6//12 RE 0.02 HM MC 0.63 6//9
1001957 58 F 6//60 NO PL RE 0.1 6//60 NS4 0.33 6//18
1001987 69 F 6//12 6//36 LE 0.17 6//36 NS2 PSCC1 0.63 6//9
1001994 65 F 6//18 6//36 LE 0.17 6//36 NS3 1 6//6
1002008 54 F 6//18 2//60 P P P LE 0.04 2//60 NS3 PSCC3 0.63 6//9
1002018 57 F CFC 6//18 RE 0.02 CFC MC 0.63 6//9
1002096 58 F 6//60 6//12 RE 0.1 6//60 NS3 PSCC1 0.33 6//18
1002111 59 F 6//18 5//60 LE 0.08 5//60 NS2 PSCC2 0.63 6//9
1002121 59 F 6//12 5//60 P P LE 0.08 5//60 MC 0.5 6//12
1002137 61 F 6//36 6//12 RE 0.17 6//36 NS3 0.63 6//9 COMBINED POAG
1002139 63 F 6//9 6//18 P LE 0.33 6//18 NS2 1 6//6
1002143 63 F 6//18 6//36 LE 0.17 6//36 NS3 0.08 5//60 DENSE SK
1002173 61 F 6//18 3//60 LE 0.05 3//60 MC 0.1 6//60 BRVO
1002180 60 F 3//60 6//60 P RE 0.05 3//60 MC 0.63 6//9
1002197 67 F 5//60 5//60 RE 0.08 5//60 NS2 PSCC3 0.63 6//9
1002187 66 F 6//12 6//60 LE 0.1 6//60 NS2 PSCC1 0.63 6//9
1002221 70 F 6//60 3//60 P P LE 0.05 3//60 NS2 PSCC2 0.63 6//9
1002269 48 F 6//60  6//60 P RE 0.1 6//60 NS3 0.5 6//12
1002274 65 F 5//60 6//18 RE 0.08 5//60 NS3 PSCC2 0.63 6//9
1002275 61 F 3//60 6//12 RE 0.05 3//60 NS2 PSCC1 0.63 6//9
1002341 60 F PL+ 6//24 RE 0 PL+ MC 0.63 6//9
1002354 65 F 5//60 5//60 LE 0.08 5//60 NS3 PSCC2 0.63 6//9
1002366 62 F 6//12 CFC LE 0.02 CFC MC 0.63 6//9
1002368 60 F 6//36 6//60 P P LE 0.1 6//60 NS2 PSCC2 0.63 6//9
1002373 65 F 6//24 6//12 RE 0.25 6//24 NS3 0.63 6//9 COMBINED
1002379 61 F PL+ 6//36 RE 0 PL+ MC 0.63 6//9
1002385 56 F 6//24 1//60 LE 0.02 1//60 NS4 PSCC1 0.5 6//12
1002410 59 F 1//60 2//60 RE 0.02 1//60 NS3 PSCC2 1 6//6
1002442 67 F 6//36 1//60 LE 0.02 1//60 NS2 PSCC2 0.5 6//12
1002476 65 F 6//24 3//60 P P LE 0.05 3//60 NS3 PSCC1 0.63 6//9
1002566 68 F PL+ 6//36 RE 0 PL+ MC 0.17 6//36 SFIOL PXF
1002640 59 F 5//60 PL+ P P LE 0 PL+ MC 0.33 6//18
1002650 57 F 6//12 CFC LE 0.02 CFC NS4 PSCC2 1 6//6
1002660 59 F 5//60 6//18 RE 0.08 5//60 NS3 PSCC1 0.5 6//12
1002703 54 F 6//24 1//60 LE 0.1 1//60 NS3 PSCC1 0.25 6//24
1002717 59 F 6//60 PL+ LE 0 MC 0.63 6//9
1002724 58 F 2//60 1//60 LE 0.02 1//60 NS3 PSCC2 0.63 6//9
1002752 60 F 5//60 5//60 LE 0.08 5//60 NS3 PSCC2 0.5 6//12
1002773 60 F 1//60 6//36 P RE 0.02 1//60 NS3 PSCC2 0.17 6//36 DENSE SK
1002778 62 F 6//36 1//60 P LE 0.02 1//60 NS3 0.63 6//9
1002855 59 F 6//12 5//60 LE 0.08 5//60 NS3 PSCC1 0.33 6//18
1002944 64 F 6//36 2//60 LE 0.04 2//60 NS2 PSCC2 0.17 6//36
1002950 63 F 5//60 3//60 LE 0.05 3//60 NS3 PSCC2 0.5 6//12
1003030 58 F 6//18 6//60 LE 0.1 6//60 NS2 PSCC1 0.63 6//9
1003060 58 F 6//12 2//60 P LE 0.04 2//60 NS4 0.5 6//12
1003081 63 F 1//60 5//60 RE 0.02 1//60 MC 0.25 6//24 DENSE SK
1003099 57 F 3//60 6//24 RE 0.05 3//60 NS3 PSCC1 0.1 6//60
1003146 57 F 1//60 05//60 RE 0.02 1//60 NS2 PSCC3 0.63 6//9
61 F 1//60 1//60 LE 0.02 1//60 MC 1 6//6
1011483 65 F 5//60 6//12 P RE 0.08 5//60 NS3 PSCC1 1 6//6
1011522 62 F 3//60 2//60 LE 0.04 2//60 NS4 1 6//6
1011528 60 F PL+ 6//6 RE 0 PL+ MC 0.63 6//9
1011529 63 F 6//36 4//60 LE 0.07 4//60 MC 0.5 6//12
1011530 59 F 6//36 1//60 0 0.02 1//60 NS3 PSCC 0.25 6//24
1011541 57 F 6//36 4//60 LE 0.07 4//60 NS3 PSCC2 0.25 6//24
1011650 59 F 6//36 3//60 LE 0.05 3//60 NS3 PSCC2 0.5 6//12
1011690 58 F 5//60 6//60 P RE 0.08 5//60 PSCC2 0.17 6//36
1011691 69 F 6//6 6//24 LE 0.25 6//24 NS2 1 6//6
1011694 64 F 6//18 PL+ LE 0 PL+ MC 0.63 6//9
1011711 59 F 6//36 6//24 P RE 0.17 6//36 NS3 0.63 6//9
1011819 63 F 5//60 6//9 P P RE 0.08 5//60 NS3 PSCC 0.02 CFC
1011860 62 F 6//9 6//24 LE 0.25 6//24 NS3 0.33 6//18
1011879 65 F PL+ 1//60 RE 0 PL+ MC 1 6//6
1011889 63 F 6//24 5//60 P P P LE 0.08 5//60 NS3 PSCC2 1 6//6
1011898 66 F 3//60 6//12 RE 0.05 3//60 NS4 PSCC 1 6//6
1011924 59 F 6//36 3//60 LE 0.05 3//60 NS2 PSCC2 0.63 6//9
1011925 58 F CFC 3//60 RE 0.02 CFC MC 0.33 6//18 COMBINED
1011932 59 F 3//60 6//24 RE 0.05 3//60 NS3 PSCC 0.63 6//9
1011933 60 F 6//60 PL+ P LE 0 PL+ MC 0.63 6//9
1011934 62 F 4//60 6//24 RE 0.07 4//60 NS2 PSCC2 1 6//6
1011948 60 F PL+ PL+ RE 0 PL+ MC 1 6//6
1011949 62 F 6//9 HM LE 0.02 HM NS4 1 6//6
1011952 57 F 3//60 1//60 P LE 0.02 1//60 NS3 PSCC1 0.63 6//9
1011958 54 F HM 5//60 RE 0.02 HM MC 1 6//6
1011969 57 F 2//60 1//60 LE 0.02 1//60 NS3 PSCC3 1 6//6
1011973 60 F 5//60 6//24 P RE 0.08 5//60 NS4 1 6//6
1011974 59 F 6//18 6//12 RE 0.33 6//18 NS2 0.63 6//9
1011975 60 F 6//18 6//24 P P P LE 0.25 6//24 NS3 1 6//6
1011975 63 F 3//60 6//12 RE 0.05 3//60 NS2 PSCC2 1 6//6
1011991 63 F 1//60 6//9 RE 0.02 1//60 NS3 PSCC2 0.63 6//9
1011992 63 F 5//60 6//60 RE 0.08 5//60 NS3 PSCC1 1 6//6
1011993 62 F 6//12 1//60 LE 0.02 1//60 NS3 PSCC1 1 6//6
1011994 61 F 6//18 3//60 P LE 0.05 3//60 NS3 PSCC2 0.5 6//12
1011996 60 F 6//18 PL+ LE 0 PL+ MC 0.33 6//18
1011997 67 F 6//36 3//60 LE 0.05 3//60 NS2 PSCC2 0.63 6//9
1012009 66 F 6//12 5//60 P P LE 0.08 5//60 NS2 PSCC1 0.63 6//9
1012014 49 F 5//60 6//12 RE 0.08 5//60 NS3 PSCC1 0.63 6//9
1012015 65 F 6//60 3//60 LE 0.05 3//60 NS2 PSCC3 0.63 6//9
1012021 54 F 6//36 PL+ LE 0 PL+ MC 1 6//6
1012078 56 F 2//60 6//24 RE 0.04 2//60 NS3 PSCC2 0.63 6//9
1012113 59 F 6//12 6//60 LE 0.1 6//60 NS3 1 6//6
1012114 60 F HM 6//12 RE 0.02 HM MC 0.63 6//9
1012116 60 F 6//60 6//36 RE 0.1 6//60 NS4 0.63 6//9
1012148 65 F 6//12 6//18 LE 0.33 6//18 NS2 0.63 6//9
1012149 64 F 6//18 6//36 LE 0.17 6//36 NS3 1 6//6
1012158 62 F 6//18 2//60 P P LE 0.04 2//60 NS3 PSCC3 0.63 6//9
1012167 60 F CFC 6//18 RE 0.02 CFC MC 0.63 6//9
1012168 66 F 6//60 6//12 RE 0.1 6//60 NS3 0.33 6//18
1012172 61 F 6//24 6//36 LE 0.17 6//36 NS3 0.63 6//9
1012188 59 F 5//60 6//60 RE 0.08 5//60 NS2 PSCC2 0.63 6//9
1012243 59 F 6//36 6//12 RE 0.17 6//36 NS3 0.63 6//9 COMBINED
1012261 57 F 6//9 6//18 P LE 0.33 6//18 NS2 1 6//6
1012262 54 F 6//18 6//36 LE 0.17 6//36 NS3 1 6//6 DENSE SK
1012270 68 F 6//60 6//36 RE 0.1 6//60 NS3 1 6//6 PCR+SFIOL
1012296 59 F 3//60 6//60 P RE 0.05 3//60 NS2 PSCC3 0.63 6//9
1012304 73 F 5//60 5//60 RE 0.08 5//60 NS2 PSCC1 1 6//6
1012305 62 F 6//12 6//60 LE 0.1 6//60 NS2 PSCC1 0.08 5//60
1012306 65 F 6//60 3//60 P LE 0.05 3//60 NS3 PSCC1 0.25 6//24
1012306 69 F 6//60  6//60 P RE 0.1 6//60 NS3 0.1 6//60
1012307 69 F 5//60 6//18 RE 0.08 5//60 NS3 PSCC1 0.63 6//9
1012340 59 F 3//60 6//12 RE 0.05 3//60 NS2 PSCC2 0.63 6//9
1012345 58 F 6//36 PL+ LE 0 PL+ MC 0.63 6//9
1012396 59 F 6//12 PL+ LE 0 PL+ MC 0.63 6//9
1012422 59 F 2//60 5//60 RE 0.04 2//60 NS3 PSCC1 1 6//6
1012448 63 F 6//36 6//60 P LE 0.1 6//60 NS2 PSCC2 0.63 6//9
1012451 58 F 6//24 6//12 RE 0.25 6//24 NS3 PSCC 0.5 6//12 COMBINED
1012454 58 F PL+ 6//36 RE 0 PL+ MC 0.63 6//9
1012457 69 F 6//24 1//60 LE 0.02 1//60 MC 0.5 6//12
1012479 63 F 1//60 2//60 RE 0.02 1//60 NS3 PSCC2 0.63 6//9
1012565 65 F 6//36 1//60 LE 0.02 1//60 NS4 PSCC2 0.63 6//9
1012572 57 F 6//24 3//60 P P LE 0.05 3//60 MC 0.63 6//9
1012667 58 F PL+ 0.5//60 RE 0 PL+ MC 0.63 6//9
1022036 66 F 5//60 5//60 RE 0.08 5//60 PSCC2 1 6//6
1022121 61 F 6//12 CFC LE 0.02 CFC MC 0.5 6//12
1022142 65 F 6//12 5//60 P P LE 0.08 5//60 NS2 PSCC1 0.1 6//60
1022254 63 F 6//36 PL+ LE 0 PL+ MC 0.33 6//18
1022296 59 F 2//60 1//60 LE 0.02 1//60 MC 1 6//6
1022319 57 F 6//12 6//60 LE 0.1 6//60 NS1 PSCC2 0.5 6//12
1022330 59 F HM 6//12 RE 0.02 HM NS2 PSCC3 0.33 6//18
1022337 67 F 6//60 NO PL P RE 0.1 6//60 NS2 PSCC1 0.5 6//12
1022341 58 F 6//12 6//60 P LE 0.1 6//60 NS3 0.25 6//24 DENSE SK
1022343 69 F 6//18 6//60 LE 0.1 6//60 NS3 PSCC1 0.63 6//9
1022346 64 F 6//18 2//60 P P LE 0.02 2//60 NS2 PSCC2 0.63 6//9
1022415 59 F 6//24 6//36 LE 0.33 6//36 NS3 0.63 6//9
1022426 60 F 6//18 6//24 LE 0.25 6//24 NS2 0.33 6//18
1022427 62 F 5//60 6//60 RE 0.08 5//60 NS4 0.5 6//12
1022427 64 F 6//60 1//60 LE 0.02 1//60 MC 0.33 6//18
1022470 63 F 6//12 5//60 LE 0.08 5//60 NS3 PSCC1 0.5 6//12
1022490 61 F 6//9 6//18 LE 0.17 6//18 PSCC2 0.5 6//12
1022493 58 F 6//60 6//36 RE 0.1 6//60 NS2 PSCC1 0.25 6//24
1022521 57 F 6//60  6//60 RE 0.1 6//60 NS3 0.5 6//12
1022536 60 F 5//60 6//18 RE 0.08 5//60 NS2 PSCC2 0.5 6//12
1022538 62 F 3//60 6//12 RE 0.05 3//60 NS3 PSCC3 1 6//6
1022541 57 F 6//36 PL+ LE 0 PL+ MC 0.63 6//9
1022546 62 F 6//60 PL+ LE 0 PL+ MC 1 6//6
1022561 60 F 4//60 2//60 LE 0.04 2//60 NS2 PSCC3 1 6//6
1022563 58 F PL+ 6//24 RE 0 PL+ MC 1 6//6
1022564 70 F 6//12 PL+ LE 0 PL+ MC 0.63 6//9
1022548 56 F 2//60 5//60 LE 0.08 5//60 NS3 PSCC1 0.25 6//24
1022568 57 F 6//12 CFC LE 0.02 CFC NS4 PSCC1 0.25 6//24
1022569 62 F 6//36 6//60 P P LE 0.1 6//60 NS3 0.5 6//12
1022570 68 F 6//24 6//12 RE 0.25 6//24 NS1 PSCC1 0.63 6//9
1022659 66 F 1//60 2//60 RE 0.02 1//60 NS3 PSCC1 0.63 6//9
1022669 63 F 6//36 1//60 LE 0.02 1//60 NS2 PSCC3 0.63 6//9
1022696 65 F PL+ 0.5//60 P P RE 0 PL+ MC 0.63 6//9
1022706 56 F 5//60 6//24 RE 0.08 5//60 NS4 0.02 CFC
1022709 52 F 0.5//60 1//60 RE 0.02 0.5//60 NS3 PSCC1 0.33 6//18
1022721 59 F PL+ 6//36 RE 0 PL+ MC 1 6//6
1022722 56 F 5//60 5//60 LE 0.08 5//60 NS3 PSCC1 1 6//6
1022737 60 F 5//60 PL+ P P LE 0 PL+ MC 1 6//6
1022744 61 F 6//12 CFC LE 0.02 CFC MC 1 6//6
1022748 66 F 6//12 5//60 LE 0.08 5//60 NS3 PSCC1 0.63 6//9
1022767 65 F 6//60 PL+ LE 0 PL+ MC 1 6//6
1022768 54 F 2//60 1//60 P LE 0.02 1//60 MC 1 6//6
1022787 57 F 5//60 5//60 P LE 0.08 5//60 NS2 PSCC2 0.63 6//9
1022841 58 F 1//60 6//36 RE 0.02 1//60 NS2 PSCC3 0.63 6//9
1022860 59 F 6//12 5//60 P LE 0.08 5//60 NS4 1 6//6
1022864 60 F 6//36 2//60 LE 0.04 2//60 NS2 PSCC3 0.63 6//9
1022871 63 F 6//36 5//60 P P P LE 0.08 5//60 NS3 PSCC1 1 6//6
1022883 62 F 6//36 2//60 LE 0.04 2//60 NS2 PSCC2 1 6//6
1022949 63 F 6//24 PL+ LE 0 PL+ MC 0.63 6//9
1022952 62 F 1//60 5//60 LE 0.02 1//60 NS3 PSCC2 0.63 6//9
1022953 61 F PL+ 1//60 RE 0 PL+ MC 0.63 6//9
1022963 60 F 3//60 6//24 P RE 0.05 3//60 NS2 PSCC2 1 6//6
1022965 67 F 3//60 6//60 RE 0.05 3//60 NS4 1 6//6
1023032 66 F CFC 3//60 RE 0.02 CFC MC 0.63 6//9
1023048 70 F 3//60 6//24 P P RE 0.05 3//60 NS2 PSCC2 0.5 6//12
1023075 65 F 4//60 6//24 RE 0.07 4//60 NS3 PSCC1 0.5 6//12 COMBINED
1023203 61 F 6//18 6//6 RE 0.33 6//18 PSCC1 0.63 6//9
1023279 56 F 6//60 6//18 RE 0.1 6//60 NS2 PSCC2 0.63 6//9
1023517 59 F PL+ PL+ LE 0 PL+ MC 0.63 6//9
1023518 60 F 6//9 HM LE 0.02 HM MC 0.5 6//12
1023556 60 F 3//60 1//60 LE 0.02 1//60 MC 1 6//6
1023565 65 F HM 5//60 RE 0.02 HM NS4 PSCC1 0.5 6//12
1023571 64 F 2//60 1//60 LE 0.02 1//60 NS4 PSCC2 0.63 6//9
1023574 62 F 2//60 PL+ LE 0 PL+ MC 1 6//6
1023587 60 F 5//60 6//24 P P P RE 0.08 5//60 NS3 PSCC1 1 6//6
1023650 66 F 6//18 6//12 RE 0.33 6//18 NS1 PSCC1 0.5 6//12
1023651 61 F 6//18 6//24 LE 0.25 6//24 NS3 0.1 6//60
1023653 56 F 3//60 6//12 RE 0.05 3//60 NS3 PSCC2 0.17 6//36
1023751 67 F 5//60 5//60 RE 0.33 6//18 PSCC1 0.33 6//18
1025275 57 F 6//12 1//60 LE 0.02 1//60 NS3 PSCC 0.5 6//12 COMBINED
1025276 54 F 6//18 6//12 P LE 0.33 6//18 NS2 PSCC2 0.25 6//24
1025281 68 F 6//18 PL+ LE 0 PL+ MC  , 0.63 6//9 DENSE SK
1025282 71 F 6//36 3//60 LE 0.05 3//60 MC 0.63 6//9 PCR+SFIOL
1025289 73 F 6//18 6//12 P RE 0.33 6//18 NS2 0.17 6//36
1025290 62 F 5//60 6//12 RE 0.08 5//60 NS2 PSCC1 0.63 6//9
1025296 65 F 6//60 3//60 LE 0.05 3//60 NS2 PSCC1 0.33 6//18
1025298 69 F 5//60 HM P LE 0.02 HM NS2 PSCC1 0.5 6//12
1025304 69 F 6//36 PL+ P LE 0 PL+ NS3 0.33 6//18
1025306 59 F 2//60 NO PL RE 0.04 2//60 NS1 PSCC3 0.17 6//36
1025307 58 F 6//12 6//60 LE 0.1 6//60 NS2 PSCC1 0.5 6//12
1025345 60 F HM 6//12 RE 0.02 HM NS2 PSCC3 0.63 6//9
1025450 58 F 6//18 2//60 P LE 0.04 2//60 MC 0.33 6//18
1025523 64 F 6//60 6//12 RE 0.1 6//60 NS2 PSCC1 0.25 6//24
1025556 58 F 6//18 6//24 P P LE 0.25 6//24 NS2 PSCC2 0.33 6//18
1025610 66 F 5//60 6//60 LE 0.08 5//60 NS3 PSCC 0.5 6//12 COMBINED
1025630 61 F 6//60 1//60 LE 0.02 1//60 NS3 PSCC1 0.5 6//12
1025663 56 F HM PL+ LE 0 PL+ MC 1 6//6
1025664 59 F 6//12 5//60 LE 0.08 5//60 NS2 PSCC1 0.63 6//9
1025726 67 F 6//36 6//12 RE 0.17 6//36 NS1 PSCC2 1 6//6
1025740 65 F 6//9 6//18 P P LE 0.33 6//18 MC 1 6//6
1025763 70 F 6//18 6//36 LE 0.17 6//36 NS2 PSCC1 1 6//6
1025801 71 F 6//12 6//60 LE 0.1 6//60 PSCC2 0.5 6//12
1025932 73 F 6//60  6//60 LE 0.1 6//60 NS2 PSCC1 0.17 6//36
1025961 62 F 5//60 6//18 P P RE 0.08 5//60 NS2 PSCC1 1 6//6
1026038 69 F 6//18 PL+ LE 0 PL+ NS2 PSCC1 0.63 6//9
1026062 59 F 4//60 2//60 LE 0.04 2//60 NS2 PSCC2 0.63 6//9
1026066 58 F PL+ 6//24 RE 0 PL+ MC 0.02 CFC Glaucomatous optic atrophy
1026071 60 F 6//12 PL+ LE 0 PL+ NS2 0.33 6//18
1026094 60 F 5//60 5//60 P RE 0.08 5//60 NS2 PSCC2 0.04 2//60
1026096 62 F 2//60 5//60 P RE 0.04 2//60 NS3 1 6//6
1026131 59 F 6//12 CFC LE 0 CFC NS3 1 6//6
1026132 58 F 6//36 6//60 P LE 0.1 6//60 NS2 1 6//6
1026127 63 F 6//24 1//60 LE 0.02 1//60 NS3 0.33 6//18 COMBINED
1026128 58 F 1//60 2//60 RE 0.02 1//60 NS2 0.63 6//9
1026129 58 F 6//36 1//60 LE 0.02 1//60 NS4 0.63 6//9
1026131 69 F 6//24 3//60 LE 0.05 3//60 MC 1 6//6
1026146 65 F 5//60 6//24 RE 0.08 5//60 NS3 PSCC1 0.63 6//9
1026196 58 F 6//60 6//9 P RE 0.1 6//60 MC 1 6//6
1026227 64 F 5//60 5//60 RE 0.08 5//60 MC 0.63 6//9
1026279 65 F 6//24 1//60 P LE 0.02 1//60 NS3 1 6//6
1026285 62 F 6//60 PL+ LE 0 PL+ NS2 1 6//6
1026287 60 F 2//60 1//60 LE 0.02 1//60 NS3 1 6//6
1026289 63 F 5//60 5//60 RE 0.08 5//60 MC 1 6//6
1026135 59 F 1//60 6//36 RE 0.02 1//60 NS2 PSCC 0.63 6//9
1026137 57 F 6//36 1//60 LE 0.02 1//60 NS2 0.63 6//9
1026139 59 F 6//12 5//60 LE 0.08 5//60 NS3 1 6//6
1026138 67 F 6//36 2//60 LE 0.04 2//60 NS3 1 6//6
1026141 69 F 6//36 2//60 LE 0.02 2//60 MC 0.33 6//18 old BRVO
1026145 64 F 5//60 3//60 LE 0.05 3//60 NS4 PSCC1 0.63 6//9
1026149 59 F 6//18 6//60 P LE 0.1 6//60 NS3 0.63 6//9
1026152 52 F 6//12 2//60 LE 0.04 2//60 NS2 1 6//6
1026198 59 F 6//24 PL+ LE 0 PL+ NS3 PSCC 0.63 6//9
1026226 60 F 1//60 5//60 P P RE 0.02 1//60 NS3 PSCC 0.63 6//9
1026220 62 F PL+ 1//60 RE 0 PL+ NS3 0.63 6//9
1026235 64 F 6//18 PL+ LE 0 PL+ NS3 1 6//6
1026250 67 F 6//36 6//24 RE 0.17 6//36 NS2 0.63 6//9
1026271 63 F 6//24 6//24 P P P RE 0.25 6//24 NS3 1 6//6
1026274 66 F PL+ PL+ LE 0 PL+ NS2 0.63 6//9
